<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:06:26Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10138823" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10138823</identifier>
        <datestamp>2023-04-28</datestamp>
        <setSpec>plosmed</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS Med</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1549-1277</issn>
              <issn pub-type="epub">1549-1676</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10138823</article-id>
              <article-id pub-id-type="pmcid">PMC10138823</article-id>
              <article-id pub-id-type="pmc-uid">10138823</article-id>
              <article-id pub-id-type="pmid">37104291</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pmed.1004221</article-id>
              <article-id pub-id-type="publisher-id">PMEDICINE-D-22-02857</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Biomarkers</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Nutrition</subject>
                    <subj-group>
                      <subject>Diet</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Nutrition</subject>
                    <subj-group>
                      <subject>Diet</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Endocrinology</subject>
                    <subj-group>
                      <subject>Endocrine Disorders</subject>
                      <subj-group>
                        <subject>Diabetes Mellitus</subject>
                        <subj-group>
                          <subject>Type 2 Diabetes</subject>
                          <subj-group>
                            <subject>Diet and Type 2 Diabetes</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Metabolic Disorders</subject>
                      <subj-group>
                        <subject>Diabetes Mellitus</subject>
                        <subj-group>
                          <subject>Type 2 Diabetes</subject>
                          <subj-group>
                            <subject>Diet and Type 2 Diabetes</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Endocrinology</subject>
                    <subj-group>
                      <subject>Endocrine Disorders</subject>
                      <subj-group>
                        <subject>Diabetes Mellitus</subject>
                        <subj-group>
                          <subject>Type 2 Diabetes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Metabolic Disorders</subject>
                      <subj-group>
                        <subject>Diabetes Mellitus</subject>
                        <subj-group>
                          <subject>Type 2 Diabetes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Lipids</subject>
                      <subj-group>
                        <subject>Fatty Acids</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Materials Science</subject>
                    <subj-group>
                      <subject>Materials</subject>
                      <subj-group>
                        <subject>Pigments</subject>
                        <subj-group>
                          <subject>Organic Pigments</subject>
                          <subj-group>
                            <subject>Carotenoids</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Clinical Medicine</subject>
                    <subj-group>
                      <subject>Clinical Trials</subject>
                      <subj-group>
                        <subject>Randomized Controlled Trials</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmacology</subject>
                    <subj-group>
                      <subject>Drug Research and Development</subject>
                      <subj-group>
                        <subject>Clinical Trials</subject>
                        <subj-group>
                          <subject>Randomized Controlled Trials</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Clinical Trials</subject>
                    <subj-group>
                      <subject>Randomized Controlled Trials</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes: Integrated analysis of data from the MedLey randomised controlled trial and the EPIC-InterAct case-cohort study</article-title>
                <alt-title alt-title-type="running-head">Biomarker of the Mediterranean diet and incidence of type 2 diabetes</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2641-2313</contrib-id>
                  <name>
                    <surname>Sobiecki</surname>
                    <given-names>Jakub G.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6841-8396</contrib-id>
                  <name>
                    <surname>Imamura</surname>
                    <given-names>Fumiaki</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3866-2603</contrib-id>
                  <name>
                    <surname>Davis</surname>
                    <given-names>Courtney R.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2375-1440</contrib-id>
                  <name>
                    <surname>Sharp</surname>
                    <given-names>Stephen J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9998-051X</contrib-id>
                  <name>
                    <surname>Koulman</surname>
                    <given-names>Albert</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6184-7764</contrib-id>
                  <name>
                    <surname>Hodgson</surname>
                    <given-names>Jonathan M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9242-6364</contrib-id>
                  <name>
                    <surname>Guevara</surname>
                    <given-names>Marcela</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0830-5277</contrib-id>
                  <name>
                    <surname>Schulze</surname>
                    <given-names>Matthias B.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                  <xref rid="aff011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6560-4890</contrib-id>
                  <name>
                    <surname>Zheng</surname>
                    <given-names>Ju-Sheng</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff012" ref-type="aff">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4472-1179</contrib-id>
                  <name>
                    <surname>Agnoli</surname>
                    <given-names>Claudia</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff013" ref-type="aff">
                    <sup>13</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bonet</surname>
                    <given-names>Catalina</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff014" ref-type="aff">
                    <sup>14</sup>
                  </xref>
                  <xref rid="aff015" ref-type="aff">
                    <sup>15</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6700-0780</contrib-id>
                  <name>
                    <surname>Colorado-Yohar</surname>
                    <given-names>Sandra M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="aff016" ref-type="aff">
                    <sup>16</sup>
                  </xref>
                  <xref rid="aff017" ref-type="aff">
                    <sup>17</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5033-5966</contrib-id>
                  <name>
                    <surname>Fagherazzi</surname>
                    <given-names>Guy</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff018" ref-type="aff">
                    <sup>18</sup>
                  </xref>
                  <xref rid="aff019" ref-type="aff">
                    <sup>19</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0520-7604</contrib-id>
                  <name>
                    <surname>Franks</surname>
                    <given-names>Paul W.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff020" ref-type="aff">
                    <sup>20</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gundersen</surname>
                    <given-names>Thomas E.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff021" ref-type="aff">
                    <sup>21</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3478-4758</contrib-id>
                  <name>
                    <surname>Jannasch</surname>
                    <given-names>Franziska</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kaaks</surname>
                    <given-names>Rudolf</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff022" ref-type="aff">
                    <sup>22</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6509-6555</contrib-id>
                  <name>
                    <surname>Katzke</surname>
                    <given-names>Verena</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff022" ref-type="aff">
                    <sup>22</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0428-2426</contrib-id>
                  <name>
                    <surname>Molina-Montes</surname>
                    <given-names>Esther</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="aff023" ref-type="aff">
                    <sup>23</sup>
                  </xref>
                  <xref rid="aff024" ref-type="aff">
                    <sup>24</sup>
                  </xref>
                  <xref rid="aff025" ref-type="aff">
                    <sup>25</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5652-8459</contrib-id>
                  <name>
                    <surname>Nilsson</surname>
                    <given-names>Peter M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff020" ref-type="aff">
                    <sup>20</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Palli</surname>
                    <given-names>Domenico</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff026" ref-type="aff">
                    <sup>26</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Panico</surname>
                    <given-names>Salvatore</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff027" ref-type="aff">
                    <sup>27</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4102-6835</contrib-id>
                  <name>
                    <surname>Papier</surname>
                    <given-names>Keren</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff028" ref-type="aff">
                    <sup>28</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rolandsson</surname>
                    <given-names>Olov</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff029" ref-type="aff">
                    <sup>29</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8008-5096</contrib-id>
                  <name>
                    <surname>Sacerdote</surname>
                    <given-names>Carlotta</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff030" ref-type="aff">
                    <sup>30</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4385-2097</contrib-id>
                  <name>
                    <surname>Tjønneland</surname>
                    <given-names>Anne</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff031" ref-type="aff">
                    <sup>31</sup>
                  </xref>
                  <xref rid="aff032" ref-type="aff">
                    <sup>32</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0284-8959</contrib-id>
                  <name>
                    <surname>Tong</surname>
                    <given-names>Tammy Y. N.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff027" ref-type="aff">
                    <sup>27</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4605-435X</contrib-id>
                  <name>
                    <surname>van der Schouw</surname>
                    <given-names>Yvonne T.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff033" ref-type="aff">
                    <sup>33</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Danesh</surname>
                    <given-names>John</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff034" ref-type="aff">
                    <sup>34</sup>
                  </xref>
                  <xref rid="aff035" ref-type="aff">
                    <sup>35</sup>
                  </xref>
                  <xref rid="aff036" ref-type="aff">
                    <sup>36</sup>
                  </xref>
                  <xref rid="aff037" ref-type="aff">
                    <sup>37</sup>
                  </xref>
                  <xref rid="aff038" ref-type="aff">
                    <sup>38</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6915-9015</contrib-id>
                  <name>
                    <surname>Butterworth</surname>
                    <given-names>Adam S.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff034" ref-type="aff">
                    <sup>34</sup>
                  </xref>
                  <xref rid="aff035" ref-type="aff">
                    <sup>35</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6795-6080</contrib-id>
                  <name>
                    <surname>Riboli</surname>
                    <given-names>Elio</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff039" ref-type="aff">
                    <sup>39</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Murphy</surname>
                    <given-names>Karen J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                  <name>
                    <surname>Wareham</surname>
                    <given-names>Nicholas J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5041-248X</contrib-id>
                  <name>
                    <surname>Forouhi</surname>
                    <given-names>Nita G.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Alliance for Research in Exercise, Nutrition and Activity, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Nutritional Biomarker Laboratory, National Institute for Health Research Biomedical Research Centre, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Nutrition &amp; Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Medical School, University of Western Australia, Perth, Australia</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Navarra Public Health Institute, Pamplona, Spain</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>Navarra Institute for Health Research (IdiSNA), Pamplona, Spain</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany</addr-line>
              </aff>
              <aff id="aff012">
                <label>12</label>
                <addr-line>Key Laboratory of Growth Regulation and Translation Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China</addr-line>
              </aff>
              <aff id="aff013">
                <label>13</label>
                <addr-line>Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy</addr-line>
              </aff>
              <aff id="aff014">
                <label>14</label>
                <addr-line>Unit of Nutrition and Cancer, Catalan Institute of Oncology—ICO, L’Hospitalet de Llobregat, Barcelona, Spain</addr-line>
              </aff>
              <aff id="aff015">
                <label>15</label>
                <addr-line>Nutrition and Cancer Group, Bellvitge Biomedical Research Institute—IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain</addr-line>
              </aff>
              <aff id="aff016">
                <label>16</label>
                <addr-line>Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain</addr-line>
              </aff>
              <aff id="aff017">
                <label>17</label>
                <addr-line>Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia</addr-line>
              </aff>
              <aff id="aff018">
                <label>18</label>
                <addr-line>Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Insitute of Health, Strassen, Luxembourg</addr-line>
              </aff>
              <aff id="aff019">
                <label>19</label>
                <addr-line>Center of Epidemiology and Population Health UMR 1018, Inserm, Paris South—Paris Saclay University, Gustave Roussy Institute, Villejuif, France</addr-line>
              </aff>
              <aff id="aff020">
                <label>20</label>
                <addr-line>Department of Clinical Sciences, Lund University, Malmö, Sweden</addr-line>
              </aff>
              <aff id="aff021">
                <label>21</label>
                <addr-line>Vitas AS, Oslo, Norway</addr-line>
              </aff>
              <aff id="aff022">
                <label>22</label>
                <addr-line>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</addr-line>
              </aff>
              <aff id="aff023">
                <label>23</label>
                <addr-line>Institute of Nutrition and Food Technology (INYTA) ‘José Mataix’, Biomedical Research Centre, University of Granada, Granada, Spain</addr-line>
              </aff>
              <aff id="aff024">
                <label>24</label>
                <addr-line>Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain</addr-line>
              </aff>
              <aff id="aff025">
                <label>25</label>
                <addr-line>Department of Nutrition and Food Science, University of Granada, Granada, Spain</addr-line>
              </aff>
              <aff id="aff026">
                <label>26</label>
                <addr-line>Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network—ISPRO, Florence, Italy</addr-line>
              </aff>
              <aff id="aff027">
                <label>27</label>
                <addr-line>Department of Mental, Physical Health and Preventive Medicine, University “L. Vanvitelli”, Naples, Italy</addr-line>
              </aff>
              <aff id="aff028">
                <label>28</label>
                <addr-line>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom</addr-line>
              </aff>
              <aff id="aff029">
                <label>29</label>
                <addr-line>Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden</addr-line>
              </aff>
              <aff id="aff030">
                <label>30</label>
                <addr-line>Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy</addr-line>
              </aff>
              <aff id="aff031">
                <label>31</label>
                <addr-line>Danish Cancer Society Research Center, Copenhagen, Denmark</addr-line>
              </aff>
              <aff id="aff032">
                <label>32</label>
                <addr-line>Department of Public Health, University of Copenhagen, Copenhagen, Denmark</addr-line>
              </aff>
              <aff id="aff033">
                <label>33</label>
                <addr-line>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands</addr-line>
              </aff>
              <aff id="aff034">
                <label>34</label>
                <addr-line>BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff035">
                <label>35</label>
                <addr-line>NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff036">
                <label>36</label>
                <addr-line>British Heart Foundation Cambridge Centre of Excellence, Division of Cardiovascular Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff037">
                <label>37</label>
                <addr-line>Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff038">
                <label>38</label>
                <addr-line>Health Data Research UK Cambridge, University of Cambridge, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff039">
                <label>39</label>
                <addr-line>School of Public Health, Imperial College London, London, United Kingdom</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Popkin</surname>
                    <given-names>Barry M.</given-names>
                  </name>
                  <role>Academic Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Carolina Population Center, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p>I have read the journal’s policy and the authors of this manuscript have the following competing interests: Authors declare support from the UK Medical Research Council, British Heart Foundation, Wellcome Trust, European Research Council, Swedish Research Council and National Institute for Health Research Cambridge Biomedical Research Centre for the submitted work. FI is a member of PLOS Medicine’s editorial board. PWF reports support for the submitted work from Novo Nordisk Foundation and consulting for Zoe Limited. JD reports grants, personal fees and non-financial support from Merck Sharp &amp; Dohme (MSD), grants, personal fees and non-financial support from Novartis, grants from Pfizer and grants from AstraZeneca outside the submitted work. JD sits on the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010); the Steering Committee of UK Biobank (since 2011); the MRC International Advisory Group (ING) member, London (since 2013); the MRC High Throughput Science ‘Omics Panel Member, London (since 2013); the Scientific Advisory Committee for Sanofi (since 2013); the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis; and the Astra Zeneca Genomics Advisory Board (2018). ASB reports institutional grants outside the submitted work from AstraZeneca, Bayer, Biogen, BioMarin, Bioverativ, Novartis and Sanofi. Authors otherwise report no financial relationships with any organisations that might have an interest in the submitted work in the previous three years and no other relationships or activities that could appear to have influenced the submitted work.”</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>nita.forouhi@mrc-epid.cam.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>4</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>4</month>
                <year>2023</year>
              </pub-date>
              <volume>20</volume>
              <issue>4</issue>
              <elocation-id>e1004221</elocation-id>
              <history>
                <date date-type="received">
                  <day>2</day>
                  <month>9</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>15</day>
                  <month>3</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 Sobiecki et al</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Sobiecki et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pmed.1004221.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>Self-reported adherence to the Mediterranean diet has been modestly inversely associated with incidence of type 2 diabetes (T2D) in cohort studies. There is uncertainty about the validity and magnitude of this association due to subjective reporting of diet. The association has not been evaluated using an objectively measured biomarker of the Mediterranean diet.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods and findings</title>
                  <p>We derived a biomarker score based on 5 circulating carotenoids and 24 fatty acids that discriminated between the Mediterranean or habitual diet arms of a parallel design, 6-month partial-feeding randomised controlled trial (RCT) conducted between 2013 and 2014, the MedLey trial (128 participants out of 166 randomised). We applied this biomarker score in an observational study, the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study, to assess the association of the score with T2D incidence over an average of 9.7 years of follow-up since the baseline (1991 to 1998). We included 22,202 participants, of whom 9,453 were T2D cases, with relevant biomarkers from an original case-cohort of 27,779 participants sampled from a cohort of 340,234 people. As a secondary measure of the Mediterranean diet, we used a score estimated from dietary-self report. Within the trial, the biomarker score discriminated well between the 2 arms; the cross-validated C-statistic was 0.88 (95% confidence interval (CI) 0.82 to 0.94). The score was inversely associated with incident T2D in EPIC-InterAct: the hazard ratio (HR) per standard deviation of the score was 0.71 (95% CI: 0.65 to 0.77) following adjustment for sociodemographic, lifestyle and medical factors, and adiposity. In comparison, the HR per standard deviation of the self-reported Mediterranean diet was 0.90 (95% CI: 0.86 to 0.95). Assuming the score was causally associated with T2D, higher adherence to the Mediterranean diet in Western European adults by 10 percentiles of the score was estimated to reduce the incidence of T2D by 11% (95% CI: 7% to 14%). The study limitations included potential measurement error in nutritional biomarkers, unclear specificity of the biomarker score to the Mediterranean diet, and possible residual confounding.</p>
                </sec>
                <sec id="sec003">
                  <title>Conclusions</title>
                  <p>These findings suggest that objectively assessed adherence to the Mediterranean diet is associated with lower risk of T2D and that even modestly higher adherence may have the potential to reduce the population burden of T2D meaningfully.</p>
                </sec>
                <sec id="sec004">
                  <title>Trial registration</title>
                  <p>Australian New Zealand Clinical Trials Registry (ANZCTR) <ext-link xlink:href="http://www.anzctr.org.au/ACTRN12613000602729" ext-link-type="uri">ACTRN12613000602729</ext-link>
<ext-link xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363860" ext-link-type="uri">https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363860</ext-link>.</p>
                </sec>
              </abstract>
              <abstract abstract-type="toc">
                <p>Jakub G Sobiecki and team aim to develop a biomarker score able to discriminate between Mediterranean diet and habitual diet, and test its association with incident type 2 diabetes in a European cohort.</p>
              </abstract>
              <abstract abstract-type="summary">
                <title>Author summary</title>
                <sec id="sec005">
                  <title>Why was this study done?</title>
                  <list list-type="bullet">
                    <list-item>
                      <p>Epidemiological evidence has indicated that greater self-reported adherence to the Mediterranean diet may be associated with lower risk of new onset type 2 diabetes (T2D), but there has been uncertainty about the magnitude of association due to subjective reporting of diet.</p>
                    </list-item>
                    <list-item>
                      <p>A combination of nutritional biomarkers could better assess diet–disease associations, but this approach has rarely been considered for overall diet quality, particularly for the association between the Mediterranean diet and T2D.</p>
                    </list-item>
                  </list>
                </sec>
                <sec id="sec006">
                  <title>What did the researchers do and find?</title>
                  <list list-type="bullet">
                    <list-item>
                      <p>Blood carotenoids and fatty acids can be used as an objective measure of adherence to the Mediterranean diet, as indicated by results from a trial (<italic toggle="yes">n</italic> = 128) of adopting Mediterranean diet with provision of its key foods to study participants. These biomarkers discriminated well between the trial participants under the Mediterranean diet intervention and those randomised to continuation of habitual diet (C-statistic = 0.88).</p>
                    </list-item>
                    <list-item>
                      <p>In a study across 8 European countries (<italic toggle="yes">n</italic> = 22,202), adherence to the Mediterranean diet, estimated using a combination of nutritional biomarkers, was associated with lower risk of new onset T2D, with a stronger relationship compared to that with self-reported Mediterranean diet. The hazard ratios (HRs) (95% confidence interval (CI)) per standard deviation of adherence were 0.71 (0.65 to 0.77) and 0.90 (0.86 to 0.95), respectively.</p>
                    </list-item>
                  </list>
                </sec>
                <sec id="sec007">
                  <title>What do these findings mean?</title>
                  <list list-type="bullet">
                    <list-item>
                      <p>Adherence to the Mediterranean diet may be more beneficial for the primary prevention of T2D than previously estimated from observational dietary studies.</p>
                    </list-item>
                    <list-item>
                      <p>Even small upward differences in objectively measured Mediterranean diet may be associated with a sizeable reduction of the risk of T2D at the population level.</p>
                    </list-item>
                    <list-item>
                      <p>Causal interpretation of these findings is limited by potential measurement error in nutritional biomarkers, unclear specificity of the biomarker score to the Mediterranean diet, and possible residual confounding.</p>
                    </list-item>
                  </list>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution>National Health and Medical Research Council</institution>
                  </funding-source>
                  <award-id>#APP1050949</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>Karen J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004965</institution-id>
                      <institution>Sixth Framework Programme</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>LSHM_CT_2006_037197</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution>MRC Cambridge Initiative</institution>
                  </funding-source>
                  <award-id>RG71466</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution>MRC Cambridge Initiative</institution>
                  </funding-source>
                  <award-id>SJAH/004</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award005">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
                      <institution>Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>MR/L003120/1</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Danesh</surname>
                      <given-names>John</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award006">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000274</institution-id>
                      <institution>British Heart Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>RG/13/13/30194</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Danesh</surname>
                      <given-names>John</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award007">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000274</institution-id>
                      <institution>British Heart Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>RG/18/13/33946</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Danesh</surname>
                      <given-names>John</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award008">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100011102</institution-id>
                      <institution>Seventh Framework Programme</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>HEALTH-F2-2012-279233</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Danesh</surname>
                      <given-names>John</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award009">
                  <funding-source>
                    <institution>European Research Council</institution>
                  </funding-source>
                  <award-id>268834</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Danesh</surname>
                      <given-names>John</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award010">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100018956</institution-id>
                      <institution>NIHR Cambridge Biomedical Research Centre</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>IS-BRC-1215-20014</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5041-248X</contrib-id>
                    <name>
                      <surname>Forouhi</surname>
                      <given-names>Nita G.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award011">
                  <funding-source>
                    <institution>Health Data Research UK</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Danesh</surname>
                      <given-names>John</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award012">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008700</institution-id>
                      <institution>Centre International de Recherche sur le Cancer</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award013">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100014534</institution-id>
                      <institution>School of Public Health, Imperial College London</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award014">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100013342</institution-id>
                      <institution>NIHR Imperial Biomedical Research Centre</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award015">
                  <funding-source>
                    <institution>Danish Cancer Society</institution>
                  </funding-source>
                </award-group>
                <award-group id="award016">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004099</institution-id>
                      <institution>Ligue Contre le Cancer</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award017">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100008017</institution-id>
                      <institution>Institut Gustave-Roussy</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award018">
                  <funding-source>
                    <institution>Mutuelle Générale de l’Education Nationale</institution>
                  </funding-source>
                </award-group>
                <award-group id="award019">
                  <funding-source>
                    <institution>Institut National de la Santé et de la Recherche Médicale (INSERM)</institution>
                  </funding-source>
                </award-group>
                <award-group id="award020">
                  <funding-source>
                    <institution>German Cancer Aid</institution>
                  </funding-source>
                </award-group>
                <award-group id="award021">
                  <funding-source>
                    <institution>German Cancer Research Center</institution>
                  </funding-source>
                </award-group>
                <award-group id="award022">
                  <funding-source>
                    <institution>German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)</institution>
                  </funding-source>
                </award-group>
                <award-group id="award023">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002347</institution-id>
                      <institution>Bundesministerium für Bildung und Forschung</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award024">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100006695</institution-id>
                      <institution>Associazione Iblea per la Ricerca Epidemiologica</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award025">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100005010</institution-id>
                      <institution>Associazione Italiana per la Ricerca sul Cancro</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award026">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100007388</institution-id>
                      <institution>Compagnia di San Paolo</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award027">
                  <funding-source>
                    <institution>National Research Council and Sicilian Regional Government</institution>
                  </funding-source>
                </award-group>
                <award-group id="award028">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002999</institution-id>
                      <institution>Ministerie van Volksgezondheid, Welzijn en Sport</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award029">
                  <funding-source>
                    <institution>Netherlands Cancer Registry</institution>
                  </funding-source>
                </award-group>
                <award-group id="award030">
                  <funding-source>
                    <institution>LK Research Funds</institution>
                  </funding-source>
                </award-group>
                <award-group id="award031">
                  <funding-source>
                    <institution>Dutch Prevention Funds</institution>
                  </funding-source>
                </award-group>
                <award-group id="award032">
                  <funding-source>
                    <institution>Zorg Onderzoek Nederland</institution>
                  </funding-source>
                </award-group>
                <award-group id="award033">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100013514</institution-id>
                      <institution>Wereld Kanker Onderzoek Fonds</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award034">
                  <funding-source>
                    <institution>Statistics Netherlands</institution>
                  </funding-source>
                </award-group>
                <award-group id="award035">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004587</institution-id>
                      <institution>Instituto de Salud Carlos III</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="award036">
                  <funding-source>
                    <institution>Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra</institution>
                  </funding-source>
                </award-group>
                <award-group id="award037">
                  <funding-source>
                    <institution>Catalan Institute of Oncology</institution>
                  </funding-source>
                </award-group>
                <award-group id="award038">
                  <funding-source>
                    <institution>Swedish Cancer Society</institution>
                  </funding-source>
                </award-group>
                <award-group id="award039">
                  <funding-source>
                    <institution>Swedish Research Council</institution>
                  </funding-source>
                </award-group>
                <award-group id="award040">
                  <funding-source>
                    <institution>Councils of Skåne and Västerbotten</institution>
                  </funding-source>
                </award-group>
                <award-group id="award041">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000289</institution-id>
                      <institution>Cancer Research UK</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>14136</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award042">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000289</institution-id>
                      <institution>Cancer Research UK</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>C8221/A29017</award-id>
                </award-group>
                <award-group id="award043">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
                      <institution>Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1000143</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award044">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
                      <institution>Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>MR/M012190/1</award-id>
                </award-group>
                <award-group id="award045">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
                      <institution>Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>MC_UU_00006/1</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award046">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
                      <institution>Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>MC_UU_00006/3</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1422-2993</contrib-id>
                    <name>
                      <surname>Wareham</surname>
                      <given-names>Nicholas J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award047">
                  <funding-source>
                    <institution>Federal Ministry of Education and Research and the State of Brandenburg</institution>
                  </funding-source>
                  <award-id>DZD grant 82DZD03D03</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0830-5277</contrib-id>
                    <name>
                      <surname>Schulze</surname>
                      <given-names>Matthias B.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award048">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100018928</institution-id>
                      <institution>Westlake University</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>YSYY0209</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6560-4890</contrib-id>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>Ju-Sheng</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award049">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100010665</institution-id>
                      <institution>H2020 Marie Skłodowska-Curie Actions</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>701708</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6560-4890</contrib-id>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>Ju-Sheng</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award050">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004191</institution-id>
                      <institution>Novo Nordisk</institution>
                    </institution-wrap>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0520-7604</contrib-id>
                    <name>
                      <surname>Franks</surname>
                      <given-names>Paul W.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award051">
                  <funding-source>
                    <institution>Swedish Diabetes Association</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0520-7604</contrib-id>
                    <name>
                      <surname>Franks</surname>
                      <given-names>Paul W.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award052">
                  <funding-source>
                    <institution>Swedish Heart-Lung Foundation</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0520-7604</contrib-id>
                    <name>
                      <surname>Franks</surname>
                      <given-names>Paul W.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award053">
                  <funding-source>
                    <institution>European Research Council</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0520-7604</contrib-id>
                    <name>
                      <surname>Franks</surname>
                      <given-names>Paul W.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award054">
                  <funding-source>
                    <institution>Imperial College Biomedical Research Centre</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6795-6080</contrib-id>
                    <name>
                      <surname>Riboli</surname>
                      <given-names>Elio</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>The MedLey trial was funded by a National Health and Medical Research Council Grant (#APP1050949 to KJM). The InterAct project was funded by the EU FP6 programme (grant number LSHM_CT_2006_037197 to NJW). Biomarker measurements for carotenoids were funded jointly by the InterAct project, the EPIC-CVD project, and the MRC Cambridge Initiative (RG71466 and SJAH/004 to NJW, NGF, JD, AB). EPIC-CVD has been supported by the UK Medical Research Council (MR/L003120/1 to ASB and JD), the British Heart Foundation (RG/13/13/30194 and RG/18/13/33946 to ASB and JD), the European Commission Framework Programme 7 (HEALTH-F2-2012-279233 to ASB and JD), the European Research Council (268834 to ASB and JD), and the National Institute for Health Research (NIHR; Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust, BRC-1215-20014 to ASB and JD). This work was also supported by Health Data Research UK (to ASB and JD), which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), and Wellcome. The coordination of EPIC is financially supported by the International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). The national cohorts are supported by: Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Federal Ministry of Education and Research (BMBF) (Germany); Associazione Iblea Ricerca Epidemiologica (A.I.R.E. – ONLUS) Ragusa, Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, Compagnia di San Paolo, National Research Council and Sicilian Regional Government (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS) - Instituto de Salud Carlos III (ISCIII), Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology - ICO (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden); Cancer Research UK (14136 to NJW; C8221/A29017), Medical Research Council (1000143 to NJW; MR/M012190/1) (United Kingdom). JGS was supported by the MRC PhD studentship. NJW, NGF, and FI acknowledge funding from the Medical Research Council Epidemiology Unit (MC_UU_00006/1, MC_UU_00006/3); and NJW, NGF and AK from the NIHR Cambridge Biomedical Research Centre (IS-BRC-1215-20014; NIHR203312). NGF and JD are NIHR Senior Investigators. JD holds a British Heart Foundation Professorship. MBS acknowledges funding from the Federal Ministry of Education and Research and the State of Brandenburg (DZD grant 82DZD03D03). JSZ has received funding from Westlake University (No YSYY0209) and European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 701708. PWF has received funding from Novo Nordisk, Swedish Diabetes Association, Swedish Heart-Lung Foundation, European Research Council. ER has received funding from Imperial College Biomedical Research Centre. The funders of the studies had no role in the study design, data collection, data analysis, data interpretation, or report preparation.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="2"/>
                <page-count count="23"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Data from the MedLey trial contains sensitive participant information. For data access, please contact the University of South Australia Human Research Ethics Committee at <email>humanethics@unisa.edu.au</email> or <email>researchintegrity@unisa.edu.au</email>. EPIC-InterAct Study data cannot be deposited publicly as these collaborative data originate from multiple research institutions across eight European countries with different legal frameworks. The authors confirm that researchers seeking the analysis dataset for this work can submit a data request to the EPIC-InterAct study central contact point by emailing <email>interact@mrc-epid.cam.ac.uk</email>.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Data from the MedLey trial contains sensitive participant information. For data access, please contact the University of South Australia Human Research Ethics Committee at <email>humanethics@unisa.edu.au</email> or <email>researchintegrity@unisa.edu.au</email>. EPIC-InterAct Study data cannot be deposited publicly as these collaborative data originate from multiple research institutions across eight European countries with different legal frameworks. The authors confirm that researchers seeking the analysis dataset for this work can submit a data request to the EPIC-InterAct study central contact point by emailing <email>interact@mrc-epid.cam.ac.uk</email>.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec008">
              <title>Introduction</title>
              <p>The Mediterranean diet is a dietary pattern typically characterised by high consumption of vegetables, legumes, fruit, nuts, grains, fish and seafood, virgin olive oil, and moderate intake of meat, dairy, and wine. It has been reported to be associated with decreased incidence of multiple noncommunicable diseases including type 2 diabetes (T2D) [<xref rid="pmed.1004221.ref001" ref-type="bibr">1</xref>,<xref rid="pmed.1004221.ref002" ref-type="bibr">2</xref>]. However, the evidence on the Mediterranean diet for prevention of T2D stems predominantly from observational research using self-reported dietary assessment, with modest effect sizes [<xref rid="pmed.1004221.ref003" ref-type="bibr">3</xref>]. Dietary self-report is subject to systematic and random measurement error that may bias the associations with disease risk in an unknown direction [<xref rid="pmed.1004221.ref004" ref-type="bibr">4</xref>]. Thus, the relationship between the Mediterranean diet and the incidence of T2D may have been misquantified. Uncertainty about the validity and size of this association limits robustness of the evidence for this dietary pattern and T2D incidence [<xref rid="pmed.1004221.ref003" ref-type="bibr">3</xref>].</p>
              <p>Nutritional biomarkers can complement the self-reported assessment of habitual dietary exposure. Dietary patterns, however, lack biologically plausible single biomarkers and, therefore, necessitate combining multiple analytes into composite biomarker scores [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>,<xref rid="pmed.1004221.ref006" ref-type="bibr">6</xref>]. Research on the derivation of such a score of the Mediterranean diet has had a number of limitations. Previous studies used mostly cross-sectional designs without external validation [<xref rid="pmed.1004221.ref007" ref-type="bibr">7</xref>], and though evidence from feeding [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>] or experimental [<xref rid="pmed.1004221.ref008" ref-type="bibr">8</xref>] designs is promising, it has been hampered by challenges such as the different definitions of the Mediterranean diet or interventions used [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>,<xref rid="pmed.1004221.ref009" ref-type="bibr">9</xref>,<xref rid="pmed.1004221.ref010" ref-type="bibr">10</xref>], the targeting of specific populations [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>,<xref rid="pmed.1004221.ref008" ref-type="bibr">8</xref>] and the use of subgroup analyses or not fully randomised enrolment of participants [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>,<xref rid="pmed.1004221.ref011" ref-type="bibr">11</xref>]. Overall, the validity and external generalisability of biomarkers of this dietary pattern reported in the literature remains largely unknown. Given these limitations, biomarker-based assessment of the Mediterranean diet has rarely been applied to the associations with disease outcomes [<xref rid="pmed.1004221.ref007" ref-type="bibr">7</xref>] and never previously for T2D.</p>
              <p>Our objectives were to derive a nutritional biomarker score that could discriminate between the Mediterranean diet intervention and the habitual diet arms of a randomised controlled trial (RCT), the MedLey trial, and to test the association of the biomarker score with incident T2D in a population-based observational study, the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study. Additionally, we aimed to estimate the potential population impact of greater adherence to the Mediterranean diet, as assessed by the biomarker score, and future risk of T2D. We undertook a comparison between the biomarker score and a score based on self-report as previously reported in the EPIC-InterAct [<xref rid="pmed.1004221.ref012" ref-type="bibr">12</xref>].</p>
            </sec>
            <sec sec-type="materials|methods" id="sec009">
              <title>Methods</title>
              <sec id="sec010">
                <title>Study designs and populations</title>
                <p>The overall study design and participant flows are displayed in <xref rid="pmed.1004221.s011" ref-type="supplementary-material">S1 Fig</xref>. Briefly, we derived a nutritional biomarker score in the MedLey trial as an objective measure of adherence to the Mediterranean diet, and we applied the score in EPIC-InterAct to test its association with incident T2D. We developed 2 protocols for earlier iterations of this research idea as parts of broader statistical analysis plans. Key analytical decisions pertinent to the current analysis were prespecified in these documents (<xref rid="pmed.1004221.s014" ref-type="supplementary-material">S1 Protocol</xref>).</p>
                <p>The MedLey trial is an RCT that tested effects of the Mediterranean diet on cardiovascular risk factors [<xref rid="pmed.1004221.ref013" ref-type="bibr">13</xref>] and cognitive function [<xref rid="pmed.1004221.ref014" ref-type="bibr">14</xref>] among healthy adults aged ≥65 years from metropolitan Adelaide, Australia. We randomised 166 participants to either the Mediterranean diet with maintenance of baseline body weight or continuation of habitual diet for 6 months in 2013 and 2014 and measured circulating carotenoids [<xref rid="pmed.1004221.ref015" ref-type="bibr">15</xref>–<xref rid="pmed.1004221.ref018" ref-type="bibr">18</xref>] and fatty acids [<xref rid="pmed.1004221.ref015" ref-type="bibr">15</xref>,<xref rid="pmed.1004221.ref019" ref-type="bibr">19</xref>–<xref rid="pmed.1004221.ref022" ref-type="bibr">22</xref>] to assess compliance [<xref rid="pmed.1004221.ref023" ref-type="bibr">23</xref>,<xref rid="pmed.1004221.ref024" ref-type="bibr">24</xref>]. Circulating carotenoids are biomarkers of dietary carotenoids or intake of fruits and vegetable [<xref rid="pmed.1004221.ref025" ref-type="bibr">25</xref>,<xref rid="pmed.1004221.ref026" ref-type="bibr">26</xref>]. Fatty acid profiles reflect across intakes of individual fatty acids and their metabolism, and are affected by dietary fat composition, intake of fish and shellfish, dairy products, nuts, and added fats, including olive oil [<xref rid="pmed.1004221.ref027" ref-type="bibr">27</xref>–<xref rid="pmed.1004221.ref029" ref-type="bibr">29</xref>]. The Mediterranean diet intervention consisted of fortnightly sessions with the study dietitian and provision of key shelf-stable foods amounting to 30% to 35% of estimated energy requirements: virgin olive oil, low-fat Greek yoghurt, unsalted nuts, canned legumes, and canned tuna. Participants in the habitual diet control group received gift vouchers to local food stores [<xref rid="pmed.1004221.ref023" ref-type="bibr">23</xref>,<xref rid="pmed.1004221.ref024" ref-type="bibr">24</xref>].</p>
                <p>We used the MedLey trial to derive a biomarker score of discrimination between the Mediterranean and habitual diet arms based on end-of-study nutritional biomarkers. Among 137 trial completers out of 166 randomised individuals, we excluded participants with missing nutritional biomarker data (<italic toggle="yes">n</italic> = 4) and those with at least 1 biomarker value outside of the 25th percentile minus 3 times the interquartile range (IQR) or the 75th percentile plus 3 times the IQR (<italic toggle="yes">n</italic> = 5). The analytical sample (<italic toggle="yes">n</italic> = 128) included 67 participants in the Mediterranean diet group and 61 in the habitual diet arm (<xref rid="pmed.1004221.s011" ref-type="supplementary-material">S1 Fig</xref>).</p>
                <p>EPIC-InterAct Study is a case-cohort study of T2D nested within the EPIC study in 8 European countries (Denmark, France, Germany, Italy, the Netherlands, Spain, Sweden, and the United Kingdom) [<xref rid="pmed.1004221.ref030" ref-type="bibr">30</xref>]. Baseline data collection took place during 1991 to 1998. We ascertained and verified 12,403 individuals with incident T2D from a cohort of 340,234 participants with stored blood samples in the EPIC study. Incident T2D cases were ascertained from a combination of sources, including self-report, primary and secondary care registers, drug registers, hospital admissions, and mortality data, as described in detail previously [<xref rid="pmed.1004221.ref030" ref-type="bibr">30</xref>]. From the cohort of 340,234 participants, a centre-stratified subcohort was assembled by randomly selecting 16,835 individuals. A total of 16,154 participants remained in the subcohort after exclusions (<italic toggle="yes">n</italic> = 548 with prevalent diabetes; <italic toggle="yes">n</italic> = 133 with uncertain diabetes status). As a result, a case cohort was established (<italic toggle="yes">n</italic> = 27,779, including 12,403 incident T2D cases; <xref rid="pmed.1004221.s011" ref-type="supplementary-material">S1 Fig</xref>) [<xref rid="pmed.1004221.ref030" ref-type="bibr">30</xref>].</p>
                <p>For the current analysis, we excluded participants with missing biomarkers required to calculate the biomarker score (<italic toggle="yes">n</italic> = 5,577), leaving 22,202 participants, with 9,453 participants who developed incident T2D and 13,313 subcohort participants (<xref rid="pmed.1004221.s011" ref-type="supplementary-material">S1 Fig</xref>) followed over an average of 9.7 years. Excluded participants were similar to those included in the analytical sample in terms of the mean baseline age (53.0 versus 51.6 years), BMI (26.3 versus 26.1 kg/m<sup>2</sup>), and the proportion of women (59.0% versus 62.8%) based on subcohort distributions.</p>
                <p>All participants provided written informed consent and studies were approved by local ethics committees. The MedLey trial was prospectively registered in the Australian New Zealand Clinical Trials Registry (ACTRN12613000602729). This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline (<xref rid="pmed.1004221.s001" ref-type="supplementary-material">S1 Checklist</xref>) and Consolidated Standards of Reporting Trials (CONSORT) statement (<xref rid="pmed.1004221.s002" ref-type="supplementary-material">S2 Checklist</xref>).</p>
                <sec id="sec011">
                  <title>Nutritional and metabolic biomarkers</title>
                  <p>In the MedLey trial, venous blood samples were taken at baseline, 3 and 6 months post randomisation after 8 h of fasting, centrifuged and stored at −80°C. High-performance liquid chromatography (HPLC) with photo-diode array detection was used to assay carotenoids [<xref rid="pmed.1004221.ref031" ref-type="bibr">31</xref>]. Individual fatty acids were assayed in erythrocyte membranes via direct transesterification as weight% of all the fatty acids measured, followed by gas chromatographic analysis at the Waite Lipid Analysis Service (Adelaide, Australia) [<xref rid="pmed.1004221.ref032" ref-type="bibr">32</xref>]. Plasma total cholesterol (TC) was measured using a Siemens ADVIA chemistry analyser at SA Pathology (Adelaide, Australia). Laboratory staff were blinded to randomised intervention allocation.</p>
                  <p>In EPIC-InterAct, venous blood samples were collected at baseline. Plasma samples were stored in liquid nitrogen (up to −196°C). HPLC with ultraviolet light detection was used to measure carotenoids [<xref rid="pmed.1004221.ref033" ref-type="bibr">33</xref>,<xref rid="pmed.1004221.ref034" ref-type="bibr">34</xref>]. Individual plasma phospholipid fatty acids were assayed as mol% of all fatty acids using automated, high-throughput gas chromatography at the Medical Research Council Human Nutrition Research (Cambridge, United Kingdom) [<xref rid="pmed.1004221.ref035" ref-type="bibr">35</xref>,<xref rid="pmed.1004221.ref036" ref-type="bibr">36</xref>]. Serum TC was measured at the Stichting Ingenhousz Laboratory (Etten-Leur, the Netherlands) using Roche Hitachi Modular P. Haemoglobin A1c was measured in the erythrocyte fraction using the Tosoh-G8 analyser (Tosoh Bioscience, Japan). Laboratory staff were blinded to case status of participants, and samples were processed in a random order.</p>
                  <p>Five carotenoid variables were measured in both the MedLey trial and EPIC-InterAct: α-carotene, β-carotene, β-cryptoxanthin, lutein, and sum of lutein and zeaxanthin. For fatty acids measured in the MedLey trial, units were converted from weight% to mol% to harmonise the data with assays of fatty acids in the EPIC-InterAct. After exclusion of fatty acids with mean concentrations &lt;0.05 mol% of total fatty acids measured, 24 fatty acids overlapped between the MedLey trial and EPIC-InterAct.</p>
                </sec>
                <sec id="sec012">
                  <title>Measurement of covariates and self-reported diet</title>
                  <p>In the MedLey trial, questionnaires and physical examination were used to collect data on baseline characteristics. Self-reported diet was measured with 3-day weighed food diaries. Intakes of energy and ethanol were estimated using a local nutrient database [<xref rid="pmed.1004221.ref024" ref-type="bibr">24</xref>].</p>
                  <p>In the EPIC study, questionnaires and physical examination were used at baseline to collect standardised information on covariates, including sociodemographic, medical and health behavioural factors, and anthropometry. Weight, height, and waist circumference were measured at baseline in all EPIC centres, except for Umea, Sweden, where waist circumference was not measured (<italic toggle="yes">n</italic> = 1,845) [<xref rid="pmed.1004221.ref030" ref-type="bibr">30</xref>]. Subgroups of participants from France and the Oxford (UK) centre had self-reported anthropometry. Physical activity was assessed using a validated questionnaire [<xref rid="pmed.1004221.ref037" ref-type="bibr">37</xref>]. Self-reported diet was measured using country-specific, validated food frequency questionnaires or diet histories. Estimation of intake of foods, energy, and nutrients was harmonised across the EPIC cohorts [<xref rid="pmed.1004221.ref038" ref-type="bibr">38</xref>,<xref rid="pmed.1004221.ref039" ref-type="bibr">39</xref>]. Information on family history of T2D was not collected in Italy, Spain, and Oxford and Heidelberg centres. Information on current use of vitamin or mineral supplements was not collected in Heidelberg. Covariates had &lt;30% missing data within countries except for Germany with 45% of missing data for vitamin/mineral supplement use and family history of T2D. The prevalence of missing information for all countries combined was the highest for family history of T2D (22%), and otherwise up to 9% (dietary supplements), with several covariates having complete data for all participants.</p>
                  <p>As a measure of self-reported adherence to the Mediterranean diet, we used a score that EPIC-InterAct previously derived (<xref rid="pmed.1004221.s003" ref-type="supplementary-material">S1 Text</xref>) and reported an association with lower T2D incidence [<xref rid="pmed.1004221.ref012" ref-type="bibr">12</xref>].</p>
                </sec>
              </sec>
              <sec id="sec013">
                <title>Statistical analysis</title>
                <p>Stata 16.1 and R 4.0.2 were used for statistical analysis.</p>
                <sec id="sec014">
                  <title>Derivation of the biomarker score</title>
                  <p>We imputed values of fatty acids below the limit of detection using quantile regression imputation [<xref rid="pmed.1004221.ref040" ref-type="bibr">40</xref>]. In the MedLey trial, values were imputed for 5 out of the 24 fatty acids and the proportion of missingness was the highest for C17:1 at 21% and otherwise &lt;13%. In EPIC-InterAct, values were imputed for 16 fatty acids, and the corresponding proportions of missingness were 12% (also for C17:1) and &lt;6%, respectively. Fatty acids were re-scaled to sum up to 100% within the sets of fatty acids overlapping between the MedLey trial and EPIC-InterAct. Concentrations of circulating carotenoids (ng/mL) were adjusted for TC using the residual method in order to account for their correlations with dietary carotenoids [<xref rid="pmed.1004221.ref041" ref-type="bibr">41</xref>].</p>
                  <p>We used logistic elastic net regression to derive the biomarker score in MedLey trial [<xref rid="pmed.1004221.ref042" ref-type="bibr">42</xref>,<xref rid="pmed.1004221.ref043" ref-type="bibr">43</xref>]. Natural-log-transformed nutritional biomarkers measured at 6 months were used to predict the binary randomised assignment to the Mediterranean or habitual diet groups. We repeated the elastic net regression with random cross-validation 1,000 times to stabilise the variable selection and included in the final model the predictors with selection rate ≥90% [<xref rid="pmed.1004221.ref043" ref-type="bibr">43</xref>]. Ridge regression was used to calculate penalised coefficients of the final model [<xref rid="pmed.1004221.ref044" ref-type="bibr">44</xref>]. We selected the predictors from 5 carotenoid and 24 fatty acid variables and 406 pairwise interaction terms between them. The biomarker score was calculated as a linear prediction from the ridge regression model. Discriminatory performance was assessed by calculating 5-fold cross-validated C-statistic. The associated 95% confidence interval (CI) was estimated based on the Hanley and McNeil variance formula [<xref rid="pmed.1004221.ref045" ref-type="bibr">45</xref>]. Additional details on derivation of the biomarker score are provided in the Supporting information (<xref rid="pmed.1004221.s003" ref-type="supplementary-material">S1 Text</xref>).</p>
                </sec>
                <sec id="sec015">
                  <title>Associations of the biomarker score with incident T2D</title>
                  <p>In EPIC-InterAct, individual nutritional biomarkers were Winsorised at 4 standard deviations (SDs) below or above the subcohort means and were then used to calculate the biomarker score with the scoring algorithm developed as described above. The biomarker score was standardised using the means and SD and categorised into quintiles based on the distribution in the subcohort. We performed Prentice-weighted Cox regression analysis with a robust variance estimator to estimate hazard ratios (HRs) for the association between the biomarker score and incident T2D [<xref rid="pmed.1004221.ref046" ref-type="bibr">46</xref>]. Country-specific HRs were estimated and pooled using random-effects meta-analysis, followed by calculation of the 95% confidence and prediction intervals [<xref rid="pmed.1004221.ref047" ref-type="bibr">47</xref>]. Restricted cubic splines with 5 knots were used to assess potential nonlinearity of the association between the standardised biomarker score and T2D incidence. Country-specific estimates of the spline parameters were pooled with multivariate random-effects meta-analysis [<xref rid="pmed.1004221.ref048" ref-type="bibr">48</xref>].</p>
                  <p>The multivariable-adjusted model included the following covariates: age (as the underlying timescale), sex, recruitment centre, prevalent comorbidity (cancer, cardiovascular disease, hypertension, and hyperlipidaemia), family history of T2D, smoking status (never, former, and current smoker), physical activity index (inactive, moderately inactive, moderately active, and active), seasonality (sine and cosine function of the day of the year of blood draw), fasting status (&lt;3, 3–6, &gt;6 h), current use of vitamin or mineral supplements, marital status (single, married or cohabiting, divorced or separated, and widowed), educational attainment (none, primary school, technical or professional school, secondary school, and post-secondary school education), current employment, and in women, menopausal status (pre-, peri-, postmenopausal, and bilateral oophorectomy) and current hormone replacement therapy use. A further model was fitted with adjustment for adiposity (BMI and waist circumference as continuous variables; main analytical model). Additional models explored the effects of adjustment for biomarkers constituting the biomarker score. Continuous covariates were Winsorised at 4 SDs below or above the subcohort means. For comparison with the biomarker-based assessment, we estimated the HR for the association with incident T2D of the standardised score of self-reported Mediterranean diet using the main analytical model.</p>
                  <p>We examined multiplicative interactions of the biomarker score with the following covariates: age, sex, BMI, seasonality, fasting status, use of dietary supplements, physical activity, and smoking status using the adiposity-adjusted model (excluding waist circumference for interaction by BMI) and variable specifications as outlined above. Missing covariate data were imputed by multiple imputation using chained equations in 10 datasets [<xref rid="pmed.1004221.ref049" ref-type="bibr">49</xref>], accounting for exposures (biomarker score, nutritional biomarkers), the outcome, model covariates, interaction terms, and country-specific case-cohort design [<xref rid="pmed.1004221.ref050" ref-type="bibr">50</xref>]. We also performed a complete-case analysis.</p>
                  <p>To assess the potential public health impact of a feasible shift in the average population adherence to the Mediterranean diet, we modelled the population attributable fraction (PAF) [<xref rid="pmed.1004221.ref051" ref-type="bibr">51</xref>] if the value of the biomarker score for each individual in the study population were to increase by 10 percentiles, assuming a causal relationship. The PAF was estimated in the EPIC-InterAct subcohort separately in each country in the adiposity-adjusted multivariable model, and then combined across countries using random-effects meta-analysis [<xref rid="pmed.1004221.ref047" ref-type="bibr">47</xref>]. We used country-specific inverse-probability weights to account for the case-cohort design [<xref rid="pmed.1004221.ref052" ref-type="bibr">52</xref>,<xref rid="pmed.1004221.ref053" ref-type="bibr">53</xref>]. To facilitate interpretation of the PAF by comparison with an established risk factor, we estimated this measure for a 10 percentile lower BMI after removing from the multivariable model the biomarker score, waist circumference, and physical activity.</p>
                </sec>
                <sec id="sec016">
                  <title>Sensitivity analyses</title>
                  <p>We performed several sensitivity analyses to assess the robustness of the main findings. We repeated the derivation and assessment of discriminatory performance of the biomarker score in the MedLey trial with several alternative analytical decisions in the elastic net regression (<xref rid="pmed.1004221.s003" ref-type="supplementary-material">S1 Text</xref>), followed by longitudinal analysis in EPIC-InterAct for each alternative score. Using the primary biomarker score in EPIC-InterAct, time-varying effects were assessed by splitting follow-up time at 7 years and performing stratified analysis. Potential reverse causation bias was evaluated by separately (i) excluding the first 2 years of follow-up; (ii) excluding participants with prevalent major disease conditions (cancer, myocardial infarction, or stroke); and (iii) excluding participants with baseline haemoglobin A1c concentrations ≥ 6.5% (48 mmol/mol).</p>
                </sec>
                <sec id="sec017">
                  <title>Analyses conducted in response to peer review comments</title>
                  <p>We performed a graphical assessment of calibration of the biomarker score model for prediction of randomised assignment in the MedLey trial [<xref rid="pmed.1004221.ref054" ref-type="bibr">54</xref>,<xref rid="pmed.1004221.ref055" ref-type="bibr">55</xref>]. We tested the discriminatory performance of the biomarker score between ≥90th percentile versus ≤10th percentile of self-reported adherence to the Mediterranean diet (<xref rid="pmed.1004221.s003" ref-type="supplementary-material">S1 Text</xref>). We assessed the influence of use of pharmacological treatments in our analyses by evaluating: (i) distributions of users of medications by MedLey trial arms (chi-squared test); (ii) multiplicative interactions between use of medications and the biomarker score in logistic regression models for prediction of randomised assignment; (iii) re-derivation of the biomarker score with adjustment of the coefficients for use of medications in the MedLey trial and its impact on the association between the score and incidence of T2D in EPIC-InterAct; and (iv) additional adjustments of the main analytical model in EPIC-InterAct for use of medications in subsets of participants with information available on these covariates.</p>
                </sec>
              </sec>
              <sec id="sec018">
                <title>Patient and public involvement</title>
                <p>The MedLey trial intervention was piloted in a group of volunteers that led to minor adjustments in its design and delivery [<xref rid="pmed.1004221.ref056" ref-type="bibr">56</xref>]. Patients or public were otherwise not involved in study design.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec019">
              <title>Results</title>
              <p>Compared to the MedLey trial participants, the EPIC-InterAct subcohort members were younger (mean age 52 years, EPIC-InterAct, versus 71 years, MedLey trial), had lower tertiary educational attainment (20% versus 53%), were less likely to have a family history of T2D (18% versus 30%), and had higher prevalence of hypertension (36% versus 19%) and hyperlipidaemia (38% versus 17%). The study populations were similar with regards to dietary and cardiometabolic phenotypes (<bold><xref rid="pmed.1004221.t001" ref-type="table">Table 1</xref></bold>). The Mediterranean diet intervention in the MedLey trial resulted in increases in the concentrations of ß-carotene, lycopene, C22:6-n3 (docosahexaenoic), C20:2-n6 (eicosadienoic), and long- and very-long chain monounsaturated fatty acids, and decreases in the concentrations of C22:5-n6 (osbond), C17:1 (heptadecenoic) and several saturated fatty acids (<xref rid="pmed.1004221.s012" ref-type="supplementary-material">S2 Fig</xref>). The effect sizes relative to the habitual diet control group ranged from −0.67 SD for C14:0 (myristic) to 0.76 SD for C20:1 (gondoic acid). Blood levels of these biomarkers varied between the MedLey trial and EPIC-InterAct. For example, comparing median concentrations in the MedLey trial habitual diet group and ranges of medians by country in the EPIC-InterAct subcohort, we observed differences for ß-carotene (726 and 144 to 419 ng/mL), lycopene (110 and 172 to 348 ng/mL), C24:1 (1.22 and 0.32 to 0.37%mol), and C24:0 (1.07 and 0.20 to 0.26%mol) fatty acids (<xref rid="pmed.1004221.s004" ref-type="supplementary-material">S1 Table</xref>).</p>
              <table-wrap position="float" id="pmed.1004221.t001">
                <object-id pub-id-type="doi">10.1371/journal.pmed.1004221.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Baseline characteristics of participants of the MedLey randomised partial-feeding controlled trial of the Mediterranean diet and the EPIC-InterAct case-cohort study*.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pmed.1004221.t001" id="pmed.1004221.t001g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="2" colspan="1">MedLey trial</th>
                        <th align="center" colspan="2" rowspan="1">EPIC-InterAct</th>
                      </tr>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Subcohort</th>
                        <th align="center" rowspan="1" colspan="1">Cases of T2D</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of participants</td>
                        <td align="center" rowspan="1" colspan="1">128</td>
                        <td align="center" rowspan="1" colspan="1">13,313</td>
                        <td align="center" rowspan="1" colspan="1">9,453</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, years</td>
                        <td align="center" rowspan="1" colspan="1">71 (5)</td>
                        <td align="center" rowspan="1" colspan="1">52 (9)</td>
                        <td align="center" rowspan="1" colspan="1">55 (8)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Women, %</td>
                        <td align="center" rowspan="1" colspan="1">54</td>
                        <td align="center" rowspan="1" colspan="1">63</td>
                        <td align="center" rowspan="1" colspan="1">50</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Postmenopausal, %<xref rid="t001fn002" ref-type="table-fn"><sup>†</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">100</td>
                        <td align="center" rowspan="1" colspan="1">44</td>
                        <td align="center" rowspan="1" colspan="1">60</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Hormone therapy use, %<xref rid="t001fn002" ref-type="table-fn"><sup>†</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">5</td>
                        <td align="center" rowspan="1" colspan="1">14</td>
                        <td align="center" rowspan="1" colspan="1">14</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Current smokers, %</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">26</td>
                        <td align="center" rowspan="1" colspan="1">28</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Moderately active or active, %</td>
                        <td align="center" rowspan="1" colspan="1">-<xref rid="t001fn003" ref-type="table-fn"><sup>‡</sup></xref></td>
                        <td align="center" rowspan="1" colspan="1">43</td>
                        <td align="center" rowspan="1" colspan="1">38</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Tertiary education, %</td>
                        <td align="center" rowspan="1" colspan="1">56</td>
                        <td align="center" rowspan="1" colspan="1">20</td>
                        <td align="center" rowspan="1" colspan="1">13</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Currently employed, %</td>
                        <td align="center" rowspan="1" colspan="1">21</td>
                        <td align="center" rowspan="1" colspan="1">67</td>
                        <td align="center" rowspan="1" colspan="1">58</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Family history of T2D, %</td>
                        <td align="center" rowspan="1" colspan="1">31</td>
                        <td align="center" rowspan="1" colspan="1">18</td>
                        <td align="center" rowspan="1" colspan="1">34</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Disease history, %</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Hypertension</td>
                        <td align="center" rowspan="1" colspan="1">36</td>
                        <td align="center" rowspan="1" colspan="1">19</td>
                        <td align="center" rowspan="1" colspan="1">39</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Hyperlipidaemia</td>
                        <td align="center" rowspan="1" colspan="1">38</td>
                        <td align="center" rowspan="1" colspan="1">17</td>
                        <td align="center" rowspan="1" colspan="1">27</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Cardiovascular disease</td>
                        <td align="center" rowspan="1" colspan="1">5.0</td>
                        <td align="center" rowspan="1" colspan="1">1.9</td>
                        <td align="center" rowspan="1" colspan="1">4.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Cancer</td>
                        <td align="center" rowspan="1" colspan="1">-</td>
                        <td align="center" rowspan="1" colspan="1">2.4</td>
                        <td align="center" rowspan="1" colspan="1">2.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Mediterranean diet score, 0–18 points</td>
                        <td align="center" rowspan="1" colspan="1">9.7 (2.6)</td>
                        <td align="center" rowspan="1" colspan="1">8.8 (3.1)</td>
                        <td align="center" rowspan="1" colspan="1">8.5 (3.2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Score components, g/1,000 kcal</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Vegetable</td>
                        <td align="center" rowspan="1" colspan="1">83 (67)</td>
                        <td align="center" rowspan="1" colspan="1">94 (64)</td>
                        <td align="center" rowspan="1" colspan="1">92 (66)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Legumes</td>
                        <td align="center" rowspan="1" colspan="1">8.2 (17.4)</td>
                        <td align="center" rowspan="1" colspan="1">9.2 (13.2)</td>
                        <td align="center" rowspan="1" colspan="1">9.4 (14.3)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Fruits and nuts</td>
                        <td align="center" rowspan="1" colspan="1">136 (75)</td>
                        <td align="center" rowspan="1" colspan="1">123 (99)</td>
                        <td align="center" rowspan="1" colspan="1">119 (102)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Grains and grain products</td>
                        <td align="center" rowspan="1" colspan="1">72 (39)</td>
                        <td align="center" rowspan="1" colspan="1">104 (41)</td>
                        <td align="center" rowspan="1" colspan="1">103 (43)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Fish and shellfish</td>
                        <td align="center" rowspan="1" colspan="1">24 (26)</td>
                        <td align="center" rowspan="1" colspan="1">18 (16)</td>
                        <td align="center" rowspan="1" colspan="1">20 (18)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Meat and meat products</td>
                        <td align="center" rowspan="1" colspan="1">35 (32)</td>
                        <td align="center" rowspan="1" colspan="1">52 (24)</td>
                        <td align="center" rowspan="1" colspan="1">58 (25)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Milk and milk products</td>
                        <td align="center" rowspan="1" colspan="1">130 (95)</td>
                        <td align="center" rowspan="1" colspan="1">163 (114)</td>
                        <td align="center" rowspan="1" colspan="1">160 (122)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Olive oil</td>
                        <td align="center" rowspan="1" colspan="1">2.0 (3.4)</td>
                        <td align="center" rowspan="1" colspan="1">4.3 (6.3)</td>
                        <td align="center" rowspan="1" colspan="1">4.0 (6.3)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Ethanol</td>
                        <td align="center" rowspan="1" colspan="1">4.6 (5.0)</td>
                        <td align="center" rowspan="1" colspan="1">6.0 (7.7)</td>
                        <td align="center" rowspan="1" colspan="1">6.5 (8.7)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Dietary supplement use, %</td>
                        <td align="center" rowspan="1" colspan="1">66</td>
                        <td align="center" rowspan="1" colspan="1">39</td>
                        <td align="center" rowspan="1" colspan="1">41</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">26.5 (3.5)</td>
                        <td align="center" rowspan="1" colspan="1">26.1 (4.2)</td>
                        <td align="center" rowspan="1" colspan="1">29.9 (4.7)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Waist circumference, cm</td>
                        <td align="center" rowspan="1" colspan="1">90 (13)</td>
                        <td align="center" rowspan="1" colspan="1">87 (13)</td>
                        <td align="center" rowspan="1" colspan="1">98 (12)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Haemoglobin A1c, mmol/mol</td>
                        <td align="center" rowspan="1" colspan="1">-</td>
                        <td align="center" rowspan="1" colspan="1">35.9 (4.9)</td>
                        <td align="center" rowspan="1" colspan="1">43.1 (11.1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> ≥6.5% (48 mmol/mol), %</td>
                        <td align="center" rowspan="1" colspan="1">-</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">17</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Total cholesterol, mmol/L</td>
                        <td align="center" rowspan="1" colspan="1">5.2 (0.9)</td>
                        <td align="center" rowspan="1" colspan="1">5.9 (1.1)</td>
                        <td align="center" rowspan="1" colspan="1">6.1 (1.2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HDL cholesterol, mmol/L</td>
                        <td align="center" rowspan="1" colspan="1">1.65 (0.44)</td>
                        <td align="center" rowspan="1" colspan="1">1.50 (0.42)</td>
                        <td align="center" rowspan="1" colspan="1">1.25 (0.37)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Triglycerides, mmol/L</td>
                        <td align="center" rowspan="1" colspan="1">1.13 (0.45)</td>
                        <td align="center" rowspan="1" colspan="1">1.33 (0.91)</td>
                        <td align="center" rowspan="1" colspan="1">1.98 (1.41)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p>*Values are means (standard deviations) or percentages. The EPIC-InterAct subcohort participants and incident cases of T2D were independently sampled from the underlying EPIC cohort. As a feature of the case-cohort design, 564 incident cases included in the analysis were simultaneously subcohort participants.</p>
                  </fn>
                  <fn id="t001fn002">
                    <p><sup>†</sup>Calculated in women.</p>
                  </fn>
                  <fn id="t001fn003">
                    <p><sup>‡</sup>Data unavailable in the MedLey trial.</p>
                  </fn>
                  <fn id="t001fn004">
                    <p>EPIC, European Prospective Investigation into Cancer and Nutrition; HDL, high density lipoprotein; T2D, type 2 diabetes.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="sec020">
                <title>Derivation of the biomarker score</title>
                <p>The biomarker score consisted of a linear combination of 23 biomarkers in total (<xref rid="pmed.1004221.s005" ref-type="supplementary-material">S2 Table</xref>). The score distinguished 2 arms of the Mediterranean and habitual diet groups with C-statistic = 0.88 (95% CI: 0.82 to 0.94) and moderate calibration (<xref rid="pmed.1004221.s013" ref-type="supplementary-material">S3 Fig</xref>). We did not find any evidence of interaction between medication use and the biomarker score (<xref rid="pmed.1004221.s006" ref-type="supplementary-material">S3 Table</xref>). After standardisation of the score in the MedLey trial, mean end-of-trial score values were higher by 1.81 (95% CI: 1.45 to 2.18) points in the Mediterranean than the habitual diet group. In EPIC-InterAct, baseline medians of the biomarker score standardised using the overall subcohort distribution ranged between countries from −0.35 in Spain to 0.71 SD in Sweden (<bold><xref rid="pmed.1004221.g001" ref-type="fig">Fig 1</xref></bold> and <xref rid="pmed.1004221.s007" ref-type="supplementary-material">S4 Table</xref>). The C-statistic values for discrimination between extreme categories of self-reported Mediterranean diet by the biomarker score were 0.63 (95% CI: 0.38 to 0.87; <italic toggle="yes">n</italic> = 42) in the MedLey trial baseline sample and 0.59 (95% CI: 0.58 to 0.61; <italic toggle="yes">n</italic> = 4,298) in the EPIC-InterAct subcohort, with country-specific values ranging from 0.54 in Germany to 0.68 in Spain.</p>
                <fig position="float" id="pmed.1004221.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pmed.1004221.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Nutritional biomarker score of the Mediterranean diet: study-specific distribution by the MedLey trial arms post-intervention and the EPIC-InterAct subcohort by country at baseline.</title>
                    <p> The biomarker score was derived as a discriminatory model between the Mediterranean and habitual diet in the MedLey randomised partial-feeding controlled trial. Circulating carotenoids and fatty acids were used to calculate the score as linear predictions from the discriminatory model. The score was standardised separately within the MedLey trial and the EPIC-InterAct subcohort. Boxes denote the IQR and medians inside; and whiskers, values up to 1.5 IQR outside of these percentiles. EPIC, European Prospective Investigation into Cancer and Nutrition; IQR, interquartile range; UK, United Kingdom.</p>
                  </caption>
                  <graphic xlink:href="pmed.1004221.g001" position="float"/>
                </fig>
              </sec>
              <sec id="sec021">
                <title>The association of the biomarker score with incident T2D</title>
                <p>The biomarker score of the Mediterranean diet was inversely associated with incident T2D (<bold><xref rid="pmed.1004221.t002" ref-type="table">Table 2</xref></bold>). In the adiposity-adjusted multivariable model, the HR (95% CI) for the top fifth of the biomarker score compared to the bottom fifth was 0.38 (0.30 to 0.50) (p trend = 0.012). The HR (95% CI) per 1 SD was 0.71 (0.65 to 0.77) with inverse associations in all countries, moderate heterogeneity between country-specific estimates (I<sup>2</sup> = 67%) and a 95% prediction interval of 0.55 to 0.91 (<bold><xref rid="pmed.1004221.g002" ref-type="fig">Fig 2</xref></bold>). We found weak evidence of departure from linearity (p nonlinearity = 0.044, <bold><xref rid="pmed.1004221.g002" ref-type="fig">Fig 2</xref></bold>) where the inverse association levelled off in approximately the upper fifth of the distributions of the score. The association remained statistically significant after additional adjustments for individual and all biomarkers or interaction terms included in the score (<xref rid="pmed.1004221.s008" ref-type="supplementary-material">S5 Table</xref>). The estimated PAF (95% CI) was 11% (7% to 14%), indicating that the incidence of T2D could be reduced by 11% if the biomarker score were increased by 10 percentiles, assuming a causal relationship. For comparison, the estimated PAF (95% CI) for a 10 percentile lower BMI was 28% (20% to 35%).</p>
                <fig position="float" id="pmed.1004221.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pmed.1004221.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Association between the nutritional biomarker score of the Mediterranean diet and incidence of T2D in the EPIC-InterAct case-cohort study (<italic toggle="yes">n</italic> = 22,202).</title>
                    <p>The biomarker score was derived as a discriminatory model between the Mediterranean and habitual diet in the MedLey randomised partial-feeding controlled trial. Circulating carotenoids and fatty acids were used to calculate the score as linear predictions from the discriminatory model. Associations were assessed with the Prentice-weighted Cox regression and pooled by random-effects meta-analysis. Top: The diamond and error bars of the pooled estimate represent the 95% confidence and prediction intervals. Bottom: Restricted cubic splines with 5 knots were used to model the nonlinear association. The <italic toggle="yes">p</italic>-value for the test of nonlinearity was 0.044. Black solid line represents point estimates of HRs and purple area denotes the 95% CI. The 10th percentile of the subcohort distribution was used as reference. Associations were adjusted for: age (as timescale), sex, recruitment centre, prevalent cancer, cardiovascular disease, hypertension and hyperlipidaemia, familial history of type 2 diabetes, smoking status (never, former, current smoker), physical activity index (inactive, moderately inactive, moderately active, active), seasonality (sine and cosine function of the day of the year), fasting status (&lt;3, 3–6, &gt;6 h), current use of vitamin or mineral supplements, marital status (single, married or cohabiting, divorced or separated, widowed), educational attainment (none, primary school, technical or professional school, secondary school, post-secondary school education), current employment, body mass index and waist circumference, and in women, menopausal status (pre-, peri-, postmenopausal, bilateral oophorectomy) and current hormone replacement therapy use. CI, confidence interval; HR, hazard ratio; SD, standard deviation; T2D, type 2 diabetes.</p>
                  </caption>
                  <graphic xlink:href="pmed.1004221.g002" position="float"/>
                </fig>
                <table-wrap position="float" id="pmed.1004221.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pmed.1004221.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Associations between the nutritional biomarker score of the Mediterranean diet* with incidence of T2D in the European Prospective Investigation into Cancer and Nutrition-InterAct (<italic toggle="yes">n</italic> = 22,202).</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pmed.1004221.t002" id="pmed.1004221.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" colspan="1">Model</th>
                          <th align="center" colspan="5" rowspan="1">Quintiles</th>
                          <th align="center" rowspan="2" colspan="1">p<sub>trend</sub><sup>‡</sup></th>
                          <th align="center" rowspan="2" colspan="1">Per 1 SD</th>
                          <th align="center" rowspan="2" colspan="1">I<sup>2</sup>, % (95% CI)</th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Q1</th>
                          <th align="center" rowspan="1" colspan="1">Q2</th>
                          <th align="center" rowspan="1" colspan="1">Q3</th>
                          <th align="center" rowspan="1" colspan="1">Q4</th>
                          <th align="center" rowspan="1" colspan="1">Q5</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Number of cases</td>
                          <td align="center" rowspan="1" colspan="1">2,779</td>
                          <td align="center" rowspan="1" colspan="1">1,954</td>
                          <td align="center" rowspan="1" colspan="1">1,698</td>
                          <td align="center" rowspan="1" colspan="1">1,508</td>
                          <td align="center" rowspan="1" colspan="1">1,514</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">IR per 100,000 person-years</td>
                          <td align="center" rowspan="1" colspan="1">572</td>
                          <td align="center" rowspan="1" colspan="1">407</td>
                          <td align="center" rowspan="1" colspan="1">286</td>
                          <td align="center" rowspan="1" colspan="1">252</td>
                          <td align="center" rowspan="1" colspan="1">268</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Pooled HRs (95% CIs)<sup>†</sup></td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Age, sex, and centre adjusted</td>
                          <td align="center" rowspan="1" colspan="1">1.0 (Ref.)</td>
                          <td align="center" rowspan="1" colspan="1">0.64 (0.58–0.69)</td>
                          <td align="center" rowspan="1" colspan="1">0.49 (0.44–0.54)</td>
                          <td align="center" rowspan="1" colspan="1">0.40 (0.34–0.47)</td>
                          <td align="center" rowspan="1" colspan="1">0.34 (0.28–0.41)</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">0.65 (0.61–0.69)</td>
                          <td align="center" rowspan="1" colspan="1">69 (39–85)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Multivariable adjusted<sup>†</sup></td>
                          <td align="center" rowspan="1" colspan="1">1.0 (Ref.)</td>
                          <td align="center" rowspan="1" colspan="1">0.66 (0.60–0.73)</td>
                          <td align="center" rowspan="1" colspan="1">0.53 (0.46–0.60)</td>
                          <td align="center" rowspan="1" colspan="1">0.43 (0.37–0.49)</td>
                          <td align="center" rowspan="1" colspan="1">0.36 (0.29–0.45)</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.001</td>
                          <td align="center" rowspan="1" colspan="1">0.67 (0.62–0.72)</td>
                          <td align="center" rowspan="1" colspan="1">67 (33–84)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> +adiposity</td>
                          <td align="center" rowspan="1" colspan="1">1.0 (Ref.)</td>
                          <td align="center" rowspan="1" colspan="1">0.69 (0.62–0.77)</td>
                          <td align="center" rowspan="1" colspan="1">0.59 (0.52–0.67)</td>
                          <td align="center" rowspan="1" colspan="1">0.48 (0.40–0.58)</td>
                          <td align="center" rowspan="1" colspan="1">0.38 (0.30–0.50)</td>
                          <td align="center" rowspan="1" colspan="1">0.012</td>
                          <td align="center" rowspan="1" colspan="1">0.71 (0.65–0.77)</td>
                          <td align="center" rowspan="1" colspan="1">67 (30–84)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>*The biomarker score was derived as a discriminatory model between the Mediterranean and habitual diet in the MedLey randomised partial-feeding controlled trial. Circulating carotenoids and fatty acids were used to calculate the score as linear predictions from the discriminatory model.</p>
                    </fn>
                    <fn id="t002fn002">
                      <p><sup>†</sup>Hazard ratios were pooled from country-specific estimates. Multivariable adjusted model included the following covariates: age (as timescale), sex, recruitment centre, prevalent cancer, cardiovascular disease, hypertension and hyperlipidaemia, familial history of T2D, smoking status (never, former, current smoker), physical activity index (inactive, moderately inactive, moderately active, active), seasonality (sine and cosine function of the day of the year), fasting status (&lt;3, 3–6, &gt;6 h), current use of vitamin or mineral supplements, marital status (single, married or cohabiting, divorced or separated, widowed), educational attainment (none, primary school, technical or professional school, secondary school, post-secondary school education), current employment, and in women, menopausal status (pre-, peri-, postmenopausal, bilateral oophorectomy), current hormone replacement therapy use. Adjustment for adiposity included body mass index and waist circumference.</p>
                    </fn>
                    <fn id="t002fn003">
                      <p><sup>‡</sup> Generalised least-squares trend estimation method was used to calculate <italic toggle="yes">p</italic>-values for a linear trend over an ordinal variable of median biomarker scores of the 5 quintile groups.</p>
                    </fn>
                    <fn id="t002fn004">
                      <p>CI, confidence interval; HR, hazard ratio; IR, incidence rate; SD, standard deviation; T2D, type 2 diabetes.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The main result was robust to multiple sensitivity analyses which explored the effects of time of follow-up, reverse causation, alternative analytical decisions at the stage of derivation of the biomarker score, and additional adjustment for use of medications (<xref rid="pmed.1004221.s008" ref-type="supplementary-material">S5 Table</xref>). Among the potential effect modifiers, we found evidence of interaction of the biomarker score with age and the use of dietary supplements (<xref rid="pmed.1004221.s009" ref-type="supplementary-material">S6 Table</xref>). The HR (95% CI) per 1 SD of the biomarker score was 0.76 (0.69 to 0.84) in supplement users and 0.69 (0.62 to 0.75) in non-users. The stratum-specific estimates by age at baseline &lt;45, 45–60, and &gt;60 years were 0.54 (0.42 to 0.69), 0.74 (0.69 to 0.80), and 0.74 (0.67 to 0.82), respectively. The results from complete-case analysis were similar to the multiple imputation estimates (<xref rid="pmed.1004221.s009" ref-type="supplementary-material">S6 Table</xref>). The HR (95% CI) per 1 SD of the score of self-reported Mediterranean diet was 0.90 (0.86 to 0.95).</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec022">
              <title>Discussion</title>
              <p>In the current research, we combined information from experimental and observational studies to investigate the association between a composite biomarker score of adherence to the Mediterranean diet and incident T2D. The key findings were that a biomarker score derived within the MedLey RCT had a high discriminatory performance between the Mediterranean and habitual diet arms, and that when this biomarker score was applied to the pan-European EPIC-InterAct Study, there was an inverse association with incident T2D. The 95% prediction interval for this association did not include the null, suggesting that our finding would be expected to be replicated in similar populations [<xref rid="pmed.1004221.ref057" ref-type="bibr">57</xref>]. The strength of the association was greater in magnitude than that between the self-reported Mediterranean diet and T2D. Moreover, higher adherence to the Mediterranean diet (as reflected by a 10-percentile higher value of the biomarker score) could reduce the incidence of T2D by 11%, assuming a causal relationship which cannot be confirmed by the present study.</p>
              <sec id="sec023">
                <title>Comparison with previous studies</title>
                <p>Attempts to derive biomarkers of the Mediterranean diet and other dietary patterns have previously been largely confined to metabolomic profiling using cross-sectional designs [<xref rid="pmed.1004221.ref007" ref-type="bibr">7</xref>,<xref rid="pmed.1004221.ref058" ref-type="bibr">58</xref>]. In a subgroup analysis in one of the centres of the PREDIMED trial, urinary metabolomic profiles at 1 or 3 years post-randomisation were able to correctly classify 93%, 85%, and 68% of participants to their respective intervention arms of the Mediterranean diet with either olive oil or nuts and the control lower fat diet [<xref rid="pmed.1004221.ref008" ref-type="bibr">8</xref>]. Only 2 previous studies considered scores comprised of nutritional biomarkers [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>,<xref rid="pmed.1004221.ref059" ref-type="bibr">59</xref>], one of which used a hypothesis-free approach that was likely prone to confounding by non-dietary regulation of nutritional biomarkers [<xref rid="pmed.1004221.ref059" ref-type="bibr">59</xref>]. The second study used a novel feeding design of habitual diets and performed data-driven variable selection from a wider range of nutritional biomarkers than available in our investigation: serum phospholipid fatty acids, carotenoids, tocopherols, retinol, B vitamins, and 24-h urinary nitrogen, sodium, potassium, and energy expenditure estimated from the doubly labelled water technique [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>]. The study derived a biomarker score that was well correlated with quantified habitual adherence to the Mediterranean diet (r<sub>cross-validated</sub> = 0.60). It included 2 circulating carotenoids and 7 fatty acids that constituted 81% of the prediction performance, as well as urinary potassium and energy expenditure [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>]. This finding corroborates our results and the hypothesis that combinations of nutritional biomarkers, and in particular circulating carotenoids and fatty acids, can be used to objectively assess adherence to the Mediterranean diet [<xref rid="pmed.1004221.ref015" ref-type="bibr">15</xref>–<xref rid="pmed.1004221.ref022" ref-type="bibr">22</xref>]. Importantly, it also highlights the remaining biomarkers not selected into the score as potentially having limited value for assessment of the Mediterranean dietary pattern, which is supported by interventional evidence for some of these analytes, e.g., for tocopherols [<xref rid="pmed.1004221.ref016" ref-type="bibr">16</xref>]. Studies on other dietary patterns likewise suggest utility of combinations of carotenoids and fatty acids for their objective assessment [<xref rid="pmed.1004221.ref005" ref-type="bibr">5</xref>,<xref rid="pmed.1004221.ref060" ref-type="bibr">60</xref>–<xref rid="pmed.1004221.ref062" ref-type="bibr">62</xref>]. It is prudent for future research on biomarker scores of the Mediterranean diet to evaluate further groups of nutritional biomarkers in a data-driven manner. For example, biomarkers of polyphenols are promising [<xref rid="pmed.1004221.ref021" ref-type="bibr">21</xref>,<xref rid="pmed.1004221.ref063" ref-type="bibr">63</xref>], however, the evidence is limited and their utility has so far not been assessed in the context of multivariate modelling.</p>
                <p>Our work on derivation of the nutritional biomarker score of the Mediterranean diet adds to the previous literature by incorporating the strength of an RCT. Owing to the RCT design of the MedLey trial, we were able to minimise confounding by non-nutritional factors, and thus derive a biomarker score with| potentially improved generalisability to external populations. A further novelty of our work is the application of the experimentally derived score to prospective associations between dietary patterns at large and disease outcomes. To our knowledge, the only other example of derivation and application of a putative biomarker of the Mediterranean diet to associations with disease endpoints was a metabolomics-based analysis in the Spanish PREDIMED study and prospective cohorts in the USA. Similar to our analysis, it observed inverse associations for cardiovascular disease using the metabolite score observationally derived in PREDIMED across all cohorts (HR range per 1 SD: 0.71 to 0.86) and weaker or null associations when using the self-reported Mediterranean diet [<xref rid="pmed.1004221.ref064" ref-type="bibr">64</xref>]. Of note, these results also provide evidence in support of transferability of objective exposure assessment measures across populations for epidemiological investigations. This is particularly pertinent to the current manuscript in which we were unable to test the association of the biomarker score with incidence of T2D in the target population of the MedLey trial.</p>
                <p>For incident T2D, the PREDIMED trial reported a 30% risk reduction in the Mediterranean diet intervention arms relative to the control lower fat diet group (273 incident cases in 3,541 participants) [<xref rid="pmed.1004221.ref065" ref-type="bibr">65</xref>]. The CORDIOPREV trial reported a statistically nonsignificantly higher incidence of T2D in the Mediterranean diet arm compared to the lower fat control group (HR 1.35; 95% CI: 0.91 to 2.01; 107 cases in 462 participants) [<xref rid="pmed.1004221.ref066" ref-type="bibr">66</xref>]. This finding from a secondary CVD prevention trial among participants predominantly with pre-diabetes (85% prevalence) is of lower relevance to prevention of T2D in the general population than that of the PREDIMED trial. Beyond moderating effects of population characteristics, the result of the CORDIOPREV trial may have been driven towards favouring the lower fat diet by a small mean weight loss over 5 years (−1.14 kg) compared to a small average weight gain in the Mediterranean diet arm (+0.78 kg) [<xref rid="pmed.1004221.ref066" ref-type="bibr">66</xref>]. Inverse associations between the self-reported Mediterranean diet and incident T2D in middle-aged adults have previously been reported in EPIC-InterAct [<xref rid="pmed.1004221.ref012" ref-type="bibr">12</xref>] and other prospective cohorts [<xref rid="pmed.1004221.ref002" ref-type="bibr">2</xref>]. The largest reduction in the incidence between extreme categories of the self-reported adherence to the Mediterranean diet was 25% (top versus bottom fifth) [<xref rid="pmed.1004221.ref067" ref-type="bibr">67</xref>], which is a substantially smaller effect size than the 62% observed in the current study using the biomarker score.</p>
              </sec>
              <sec id="sec024">
                <title>Strengths and limitations</title>
                <p>The major strength of the current research was the use of a novel analytical approach that combined the derivation of an objective measure of the Mediterranean diet in a partial-feeding study (the MedLey RCT) and its application in a large observational study (the EPIC-InterAct Study). The RCT compared the effects of this dietary pattern (without weight loss) with continuation of habitual diet on nutritional biomarkers. Such an experimental design allowed us to derive a biomarker score of the Mediterranean diet in a manner that was free from influences of other dietary and non-dietary factors, while using a control group suitable for application of the score to study participants in an observational setting in Western countries. We used a set of biomarkers that reflect dietary exposures over the past weeks or months [<xref rid="pmed.1004221.ref068" ref-type="bibr">68</xref>] that is a desirable timeframe for assessment of habitual diet for epidemiological applications. Our analysis was based on the largest study to date of nutritional biomarkers and T2D, including over 9,000 incident cases. Among other strengths, our observational analyses adjusted for a comprehensive range of potential confounding factors and included several sensitivity analyses, compared the main results against the Mediterranean diet assessed by self-report, and modelled the population impact of greater adherence to the Mediterranean diet on future T2D risk.</p>
                <p>Our research had several limitations. The intervention in the MedLey trial was administered at one level of intensity. This allowed for modelling of the Mediterranean diet only as a binary variable and precluded objective evaluation of the dose-response relationship between the adherence to this dietary pattern and the biomarker score [<xref rid="pmed.1004221.ref069" ref-type="bibr">69</xref>]. Second, the MedLey trial was a partial-feeding RCT that may have resulted in lower adherence to the dietary components not provided (e.g., fruits and vegetables) than the food items provided as part of the Mediterranean diet intervention. Third, we used a combination of candidate biomarkers of intake, concentration, and function that are not only affected by dietary intakes, but also bioavailability, endogenous synthesis, genetic variation, homeostatic control, and nutrient metabolism [<xref rid="pmed.1004221.ref027" ref-type="bibr">27</xref>,<xref rid="pmed.1004221.ref070" ref-type="bibr">70</xref>,<xref rid="pmed.1004221.ref071" ref-type="bibr">71</xref>]. Thus, changes in nutritional biomarkers in the MedLey trial may have represented a metabolic response to a healthy diet, rather than a specific biomarker profile indicative of adherence to the Mediterranean diet. Fourth, we were unable to assess whether participants in the intervention group reached equilibrium in concentrations of nutritional biomarkers and values of the biomarker score. Fifth, the trial experienced a moderate degree of drop-outs between the randomisation and the end-of-trial assessment (20% in each arm, including missing biomarker data). Both the unknown equilibrium status and the loss to follow-up [<xref rid="pmed.1004221.ref072" ref-type="bibr">72</xref>] may have biased the derivation of the RCT score and evaluation of its performance as a classifier. The biomarker score had limited utility in discriminating between extreme categories of self-reported adherence to the Mediterranean diet; however, the measurement error due to subjective reporting and potentially insufficient construct validity of the self-reported Mediterranean diet score may have meant the C-statistics were underestimated. Sensitivity and specificity of the biomarker score, as well as external validity, remain unknown at present and require evaluation of the score in external trials of interventions with the Mediterranean diet and other dietary patterns. We also note that the MedLey trial used canned fish and legumes as a pragmatic, nontraditional approach to implementation of these components of the Mediterranean diet; however, we would not expect this method of preservation to have a materially differential effect on the biomarkers used compared to cooked fresh fish and beans cooked from dry.</p>
                <p>Limitations in the observational research in EPIC-InterAct included residual confounding as a potential source of bias with an overall unclear direction and magnitude. It was unlikely to fully account for the inverse association given its large effect size and the effect sizes of risk factors for T2D previously reported in the literature [<xref rid="pmed.1004221.ref073" ref-type="bibr">73</xref>,<xref rid="pmed.1004221.ref074" ref-type="bibr">74</xref>]. However, the above mentioned potentially limited specificity may have contributed to positive residual confounding. There may have been degradation of the nutritional biomarkers despite the storage in liquid nitrogen, but we would not expect any bias in the relative risk estimate assuming the degradation rates were non-differential by the incident case status or biomarker level. The random measurement error in the nutritional biomarkers would be expected to bias the association towards the null when considered in isolation from other sources of error, but the context of multivariable statistical modelling precludes any inference on the direction of the potential bias [<xref rid="pmed.1004221.ref004" ref-type="bibr">4</xref>]. The differential misclassification in the ascertainment of the outcome also may have biased the results in an unknown direction. We can speculate that higher adherence to the Mediterranean diet may have been associated with greater health-consciousness and healthcare-seeking behaviours, higher likelihood of T2D diagnosis, and an underestimation of the inverse association. We standardised the measures of the Mediterranean diet to improve interpretability of the results for the biomarker score over its original scale and to allow for a comparison of the effect size with that of the self-reported Mediterranean diet. This approach conditioned the effect sizes on the underlying distributions of the exposure variables in EPIC-InterAct which may have limited our quantitative and comparative interpretation [<xref rid="pmed.1004221.ref075" ref-type="bibr">75</xref>]. Similarly, our modelling of the PAF was limited by using a relative scale of the biomarker score to quantify its potential impact on population-level prevention of T2D. Public health relevance of this result was further constrained by the fact that the current evidence-base does not enable a direct interpretation of how to achieve the 10-percentile change in the score. Our analysis was not adjusted for use of medications due to incomplete availability of data on these covariates across recruitment centres (&lt;30% participants). However, sensitivity analyses adjusted for use of medications in subsets of study participants showed no appreciable differences compared with the primary results, reducing the potential for residual confounding by medication use. The use of dietary supplements was available as a binary variable that allowed only for a crude assessment of effect modification. Finally, reliability of the externally derived biomarker score applied to biomarker assays used in EPIC-InterAct remains unknown.</p>
              </sec>
              <sec id="sec025">
                <title>Implications of this research</title>
                <p>The analysis of dietary patterns aims to evaluate the cumulative impact of dietary exposures on disease risk to inform development of dietary guidelines [<xref rid="pmed.1004221.ref001" ref-type="bibr">1</xref>]. High-quality evidence on dietary patterns and the primary prevention of T2D is lacking, partly because of limitations of dietary assessment methods [<xref rid="pmed.1004221.ref003" ref-type="bibr">3</xref>]. Self-reported tools have been used almost exclusively in the published studies on this topic [<xref rid="pmed.1004221.ref003" ref-type="bibr">3</xref>,<xref rid="pmed.1004221.ref076" ref-type="bibr">76</xref>]. We have developed a method of objective assessment of the Mediterranean diet via nutritional biomarkers in order to investigate the association of this dietary pattern and T2D. Our approach of using objective biomarkers yielded substantially greater magnitude and stronger inverse associations than for the Mediterranean diet assessed with subjective methods, also consequently addressing the limitation of small effect sizes often observed in nutritional epidemiology [<xref rid="pmed.1004221.ref077" ref-type="bibr">77</xref>]. Our modelling indicates that a modest, 10-percentile increase in the objectively assessed Mediterranean diet could potentially avert 11% of new T2D cases. In comparative analysis, this effect size was approximately 40% of the estimated effect of decreasing mean BMI by 10 percentiles as an example of a well-established, causal risk factor for T2D with a large effect size [<xref rid="pmed.1004221.ref074" ref-type="bibr">74</xref>]. Of note, the inverse associations of the biomarker score with T2D in the current study were independent from measured adiposity, with no evidence of effect modification by BMI. Therefore, our finding suggests that a sizeable decrease in the incidence of T2D could potentially be achieved through improved adherence to the Mediterranean diet even in the absence of modification of body weight and across the spectrum of adiposity in the population.</p>
                <p>Our integrative approach of using a trial and an observational study with nutritional biomarkers strengthens the evidence for the utility of biomarkers in research on dietary patterns. Further investigations are warranted for a broader use of biomarkers to monitor dietary adherence in research, clinical settings, and potentially of preventive interventions in the real world. Our primary finding was consistent with interventional evidence from a Mediterranean (Spanish) population [<xref rid="pmed.1004221.ref065" ref-type="bibr">65</xref>], and it lends itself to consideration for developing dietary guidelines, public health policy, and personalised dietary advice.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec026">
              <title>Conclusions</title>
              <p>The findings of the current study have demonstrated the utility of combining circulating carotenoids and fatty acids as a composite biomarker of the Mediterranean diet. The inverse association between a biomarker score of this dietary pattern and T2D was approximately 3-fold larger than for adherence to the Mediterranean diet estimated from dietary self-report, thus raising the possibility that adherence to the Mediterranean diet is likely to be more beneficial for the primary prevention of T2D than previously estimated from observational dietary studies. These results add to the evidence in favour of adopting a Mediterranean-type diet in Western European adults for the prevention of T2D.</p>
            </sec>
            <sec id="sec027" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pmed.1004221.s001" position="float" content-type="local-data">
                <label>S1 Checklist</label>
                <caption>
                  <title>STROBE Statement—Checklist of items that should be included in reports of cohort studies.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s002" position="float" content-type="local-data">
                <label>S2 Checklist</label>
                <caption>
                  <title>CONSORT 2010 checklist of information to include when reporting a randomised trial.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s003" position="float" content-type="local-data">
                <label>S1 Text</label>
                <caption>
                  <title>Supplementary methods.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s004" position="float" content-type="local-data">
                <label>S1 Table</label>
                <caption>
                  <title>Medians (25th, 75th percentile) of circulating carotenoids and fatty acids: the MedLey trial post-intervention and the EPIC-InterAct subcohort at baseline.</title>
                  <p>Abbreviations: Hab, habitual; Med, Mediterranean.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s004.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s005" position="float" content-type="local-data">
                <label>S2 Table</label>
                <caption>
                  <title>Biomarker scores of discrimination between the Mediterranean and habitual diet in the MedLey trial.</title>
                  <p>Abbreviations: mol%, molar percent; RCT, randomised controlled trial; SD, standard deviation; wt%, weight percent; β-crypt., β-cryptoxanthin.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s005.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s006" position="float" content-type="local-data">
                <label>S3 Table</label>
                <caption>
                  <title>Percentages (numbers) of users of medications in the MedLey trial by randomised assignment at baseline (<italic toggle="yes">n</italic> = 152) and in the biomarker score derivation sample (<italic toggle="yes">n</italic> = 128).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s006.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s007" position="float" content-type="local-data">
                <label>S4 Table</label>
                <caption>
                  <title>Medians (interquartile ranges) of the nutritional biomarker score of the Mediterranean diet in the MedLey trial post-intervention and in the EPIC-InterAct subcohort.</title>
                  <p>Abbreviations: Hab, habitual; Med, Mediterranean; <italic toggle="yes">n</italic>, number of participants.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s007.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s008" position="float" content-type="local-data">
                <label>S5 Table</label>
                <caption>
                  <title>Nutritional biomarker score of the Mediterranean diet derived in the MedLey trial and incidence of type 2 diabetes in EPIC-InterAct: sensitivity analyses.</title>
                  <p>Abbreviations: CI, confidence interval; EPIC, European Prospective Investigation into Cancer and Nutrition; HR, hazard ratio; MI, myocardial infarction; RCT, randomised controlled trial; SD, standard deviation.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s008.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s009" position="float" content-type="local-data">
                <label>S6 Table</label>
                <caption>
                  <title>Nutritional biomarker score of the Mediterranean diet derived in the MedLey trial and incidence of type 2 diabetes in EPIC-InterAct: associations per 1 standard deviation by categories of covariates.</title>
                  <p>Abbreviations: CI, confidence interval; EPIC, European Prospective Investigation into Cancer and Nutrition; HR, hazard ratio; RCT, randomised controlled trial.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s009.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s010" position="float" content-type="local-data">
                <label>S7 Table</label>
                <caption>
                  <title>The score of self-reported Mediterranean diet.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s010.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s011" position="float" content-type="local-data">
                <label>S1 Fig</label>
                <caption>
                  <title>Designs of the MedLey trial and the EPIC-InterAct case-cohort study and numbers of participants included in the analysis.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s011.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s012" position="float" content-type="local-data">
                <label>S2 Fig</label>
                <caption>
                  <title>Differences in standardised means of nutritional biomarkers between the Mediterranean and habitual diet groups in the MedLey trial at 6 months.</title>
                  <p>Abbreviations: AA, arachidonic acid; ALA, α-linolenic acid; DGLA, dihomo-γ-linolenic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; FAs, fatty acids; LA, linoleic acid. Mixed linear models were used to estimate standardised differences after 6 months of partial-feeding intervention. Standardised values were calculated using baseline means and standard deviations of natural logarithm-transformed values of biomarkers. Horizontal error bars indicate 95% confidence intervals. Between 131–136 participants had non-missing biomarker data at 6 months.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s012.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s013" position="float" content-type="local-data">
                <label>S3 Fig</label>
                <caption>
                  <title>Calibration plots of the nutritional biomarker score for prediction of randomised assignment to 6 months of the Mediterranean diet (<italic toggle="yes">n</italic> = 67) versus continuation of habitual diet (<italic toggle="yes">n</italic> = 61) in the MedLey trial.</title>
                  <p>Abbreviations: AUC, area under the curve; CITL, calibration-in-the-large; E:O, ratio of expected and observed outcomes.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s013.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pmed.1004221.s014" position="float" content-type="local-data">
                <label>S1 Protocol</label>
                <caption>
                  <title>Study protocol.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pmed.1004221.s014.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank all the MedLey trial and EPIC participants and staff for their contribution to the study. The authors acknowledge the MedLey team for their support in the recruitment, data collection, and analysis during the trial. The authors acknowledge the following industry partners for donations of foods for the trial: Cobram Estate; Peanut Company of Australia; The Grains &amp; Legumes Nutrition Council; Simplot Australia Pty. Ltd.; Goodman Fielder Ltd; and The Almond Board of Australia. We thank the technical and functional operational teams of the MRC Epidemiology Unit and laboratory team at VITAS AS, Norway, for the measurements of plasma carotenoids in the EPIC-InterAct study. We thank staff from the EPIC-InterAct and EPIC-CVD Coordinating Centres for carrying out sample preparation and data-handling work, particularly Nicola Kerrison (Data Manager, MRC Epidemiology Unit, Cambridge) and Sarah Spackman (EPIC-CVD Data Manager). We acknowledge Dr. Rosario Tumino as data contributor from the Ragusa EPIC centre.</p>
              <p>The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.</p>
            </ack>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>CI</term>
                  <def>
                    <p>confidence interval</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EPIC</term>
                  <def>
                    <p>European Prospective Investigation into Cancer and Nutrition</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HPLC</term>
                  <def>
                    <p>high-performance liquid chromatography</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HR</term>
                  <def>
                    <p>hazard ratio</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IQR</term>
                  <def>
                    <p>interquartile range</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PAF</term>
                  <def>
                    <p>population attributable fraction</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RCT</term>
                  <def>
                    <p>randomised controlled trial</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SD</term>
                  <def>
                    <p>standard deviation</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TC</term>
                  <def>
                    <p>total cholesterol</p>
                  </def>
                </def-item>
                <def-item>
                  <term>T2D</term>
                  <def>
                    <p>type 2 diabetes</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="pmed.1004221.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Schulze</surname><given-names>MB</given-names></name>, <name><surname>Martínez-González</surname><given-names>MA</given-names></name>, <name><surname>Fung</surname><given-names>TT</given-names></name>, <name><surname>Lichtenstein</surname><given-names>AH</given-names></name>, <name><surname>Forouhi</surname><given-names>NG</given-names></name>. <article-title>Food based dietary patterns and chronic disease prevention</article-title>. <source>BMJ</source>. <year>2018</year>;<volume>361</volume>:<fpage>k2396</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.k2396</pub-id><?supplied-pmid 29898951?><pub-id pub-id-type="pmid">29898951</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Jannasch</surname><given-names>F</given-names></name>, <name><surname>Kröger</surname><given-names>J</given-names></name>, <name><surname>Schulze</surname><given-names>MB</given-names></name>. <article-title>Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies</article-title>. <source>J Nutr</source>. <year>2017</year>;<volume>147</volume>:<fpage>1174</fpage>–<lpage>1182</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/jn.116.242552</pub-id>
<?supplied-pmid 28424256?><pub-id pub-id-type="pmid">28424256</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Neuenschwander</surname><given-names>M</given-names></name>, <name><surname>Ballon</surname><given-names>A</given-names></name>, <name><surname>Weber</surname><given-names>KS</given-names></name>, <name><surname>Norat</surname><given-names>T</given-names></name>, <name><surname>Aune</surname><given-names>D</given-names></name>, <name><surname>Schwingshackl</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies</article-title>. <source>BMJ</source>. <year>2019</year>;<volume>366</volume>:<fpage>l2368</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.l2368</pub-id><?supplied-pmid 31270064?><pub-id pub-id-type="pmid">31270064</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Bennett</surname><given-names>DA</given-names></name>, <name><surname>Landry</surname><given-names>D</given-names></name>, <name><surname>Little</surname><given-names>J</given-names></name>, <name><surname>Minelli</surname><given-names>C</given-names></name>. <article-title>Systematic review of statistical approaches to quantify, or correct for, measurement error in a continuous exposure in nutritional epidemiology.</article-title><source>BMC Med Res Methodol</source>. <year>2017</year>;<volume>17</volume>:<fpage>1</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12874-017-0421-6</pub-id>
<?supplied-pmid 28927376?><pub-id pub-id-type="pmid">28056835</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name><surname>Pettinger</surname><given-names>M</given-names></name>, <name><surname>Lampe</surname><given-names>JW</given-names></name>, <name><surname>Tinker</surname><given-names>LF</given-names></name>, <name><surname>George</surname><given-names>SM</given-names></name>, <name><surname>Reedy</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Novel Application of Nutritional Biomarkers From a Controlled Feeding Study and an Observational Study to Characterization of Dietary Patterns in Postmenopausal Women</article-title>. <source>Am J Epidemiol</source>. <year>2021</year>;<volume>190</volume>:<fpage>2461</fpage>–<lpage>2473</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwab171</pub-id>
<?supplied-pmid 34142699?><pub-id pub-id-type="pmid">34142699</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Garcia-Aloy</surname><given-names>M</given-names></name>, <name><surname>Rabassa</surname><given-names>M</given-names></name>, <name><surname>Casas-Agustench</surname><given-names>P</given-names></name>, <name><surname>Hidalgo-Liberona</surname><given-names>N</given-names></name>, <name><surname>Llorach</surname><given-names>R</given-names></name>, <name><surname>Andres-Lacueva</surname><given-names>C</given-names></name>. <article-title>Novel strategies for improving dietary exposure assessment: Multiple-data fusion is a more accurate measure than the traditional single-biomarker approach</article-title>. <source>Trends Food Sci Technol</source>. <year>2017</year>;<volume>69</volume>:<fpage>220</fpage>–<lpage>229</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tifs.2017.04.013</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Rebholz</surname><given-names>CM</given-names></name>. <article-title>Metabolomic Biomarkers of Healthy Dietary Patterns and Cardiovascular Outcomes.</article-title><source>Curr Atheroscler Rep.</source><year>2021</year>;<volume>23</volume>:<fpage>26</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11883-021-00921-8</pub-id><?supplied-pmid 33782776?><pub-id pub-id-type="pmid">33782776</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Vázquez-Fresno</surname><given-names>R</given-names></name>, <name><surname>Llorach</surname><given-names>R</given-names></name>, <name><surname>Urpi-Sarda</surname><given-names>M</given-names></name>, <name><surname>Lupianez-Barbero</surname><given-names>A</given-names></name>, <name><surname>Estruch</surname><given-names>R</given-names></name>, <name><surname>Corella</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Metabolomic pattern analysis after Mediterranean diet intervention in a nondiabetic population: A 1- and 3-year follow-up in the PREDIMED study</article-title>. <source>J Proteome Res</source>. <year>2015</year>;<volume>14</volume>:<fpage>531</fpage>–<lpage>540</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/pr5007894</pub-id>
<?supplied-pmid 25353684?><pub-id pub-id-type="pmid">25353684</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Appel</surname><given-names>LJ</given-names></name>, <name><surname>Van Horn</surname><given-names>L</given-names></name>. <article-title>Did the PREDIMED Trial Test a Mediterranean Diet?</article-title><source>N Engl J Med</source>. <year>2013</year>;<volume>368</volume>:<fpage>1353</fpage>–<lpage>1354</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMe1301582</pub-id>
<?supplied-pmid 23550674?><pub-id pub-id-type="pmid">23550674</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Hutchins-Wiese</surname><given-names>HL</given-names></name>, <name><surname>Bales</surname><given-names>CW</given-names></name>, <name><surname>Starr</surname><given-names>KNP</given-names></name>. <article-title>Mediterranean diet scoring systems: understanding the evolution and applications for Mediterranean and non-Mediterranean countries</article-title>. <source>Br J Nutr</source>. <year>2021</year>;<fpage>1</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/S0007114521002476</pub-id>
<?supplied-pmid 34289917?><pub-id pub-id-type="pmid">34289917</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Estruch</surname><given-names>R</given-names></name>, <name><surname>Ros</surname><given-names>E</given-names></name>, <name><surname>Salas-Salvadó</surname><given-names>J</given-names></name>, <name><surname>Covas</surname><given-names>M-II</given-names></name>, <name><surname>Corella</surname><given-names>D</given-names></name>, <name><surname>Arós</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts</article-title>. <source>N Engl J Med</source>. <year>2018</year>;<volume>378</volume>:<fpage>e34</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1800389</pub-id><?supplied-pmid 29897866?><pub-id pub-id-type="pmid">29897866</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Romaguera</surname><given-names>D</given-names></name>, <name><surname>Guevara</surname><given-names>M</given-names></name>, <name><surname>Norat</surname><given-names>T</given-names></name>, <name><surname>Langenberg</surname><given-names>C</given-names></name>, <name><surname>Forouhi</surname><given-names>NG</given-names></name>, <name><surname>Sharp</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project.</article-title><source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>:<fpage>1913</fpage>–<lpage>1918</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/dc11-0891</pub-id>
<?supplied-pmid 21788627?><pub-id pub-id-type="pmid">21788627</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>CR</given-names></name>, <name><surname>Hodgson</surname><given-names>JM</given-names></name>, <name><surname>Woodman</surname><given-names>R</given-names></name>, <name><surname>Bryan</surname><given-names>J</given-names></name>, <name><surname>Wilson</surname><given-names>C</given-names></name>, <name><surname>Murphy</surname><given-names>KJ</given-names></name>. <article-title>A Mediterranean diet lowers blood pressure and improves endothelial function: Results from the MedLey randomized intervention trial</article-title>. <source>Am J Clin Nutr</source>. <year>2017</year>;<volume>105</volume>:<fpage>1305</fpage>–<lpage>1313</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/ajcn.116.146803</pub-id>
<?supplied-pmid 28424187?><pub-id pub-id-type="pmid">28424187</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Knight</surname><given-names>A</given-names></name>, <name><surname>Bryan</surname><given-names>J</given-names></name>, <name><surname>Wilson</surname><given-names>C</given-names></name>, <name><surname>Hodgson</surname><given-names>JM</given-names></name>, <name><surname>Davis</surname><given-names>CR</given-names></name>, <name><surname>Murphy</surname><given-names>KJ</given-names></name>. <article-title>The Mediterranean Diet and Cognitive Function among Healthy Older Adults in a 6-Month Randomised Controlled Trial: The MedLey Study.</article-title><source>Nutrients</source>. <year>2016</year>;<volume>8</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/NU8090579</pub-id><?supplied-pmid 27657119?><pub-id pub-id-type="pmid">27657119</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Djuric</surname><given-names>Z</given-names></name>, <name><surname>Ren</surname><given-names>J</given-names></name>, <name><surname>Blythe</surname><given-names>J</given-names></name>, <name><surname>VanLoon</surname><given-names>G</given-names></name>, <name><surname>Sen</surname><given-names>A</given-names></name>. <article-title>A Mediterranean dietary intervention in healthy American women changes plasma carotenoids and fatty acids in distinct clusters.</article-title><source>Nutr Res.</source><year>2009</year>;<volume>29</volume>:<fpage>156</fpage>–<lpage>163</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.nutres.2009.03.001</pub-id>
<?supplied-pmid 19358929?><pub-id pub-id-type="pmid">19358929</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Hagfors</surname><given-names>L</given-names></name>, <name><surname>Leanderson</surname><given-names>P</given-names></name>, <name><surname>Sköldstam</surname><given-names>L</given-names></name>, <name><surname>Andersson</surname><given-names>J</given-names></name>, <name><surname>Johansson</surname><given-names>G</given-names></name>. <article-title>Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis.</article-title><source>Nutr J</source>. <year>2003</year>;<volume>2</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1475-2891-2-5</pub-id>
<?supplied-pmid 12952549?><pub-id pub-id-type="pmid">12740043</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Marin</surname><given-names>C</given-names></name>, <name><surname>Ramirez</surname><given-names>R</given-names></name>, <name><surname>Delgado-Lista</surname><given-names>J</given-names></name>, <name><surname>Yubero-Serrano</surname><given-names>EM</given-names></name>, <name><surname>Perez-Martinez</surname><given-names>P</given-names></name>, <name><surname>Carracedo</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium</article-title>. <source>Am J Clin Nutr</source>. <year>2011</year>;<volume>93</volume>:<fpage>267</fpage>–<lpage>274</lpage>. Available from: <ext-link xlink:href="https://academic-oup-com.ezp.lib.cam.ac.uk/ajcn/article/93/2/267/4597613" ext-link-type="uri">https://academic-oup-com.ezp.lib.cam.ac.uk/ajcn/article/93/2/267/4597613</ext-link>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/ajcn.110.006866</pub-id>
<?supplied-pmid 21123460?><pub-id pub-id-type="pmid">21123460</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Itsiopoulos</surname><given-names>C</given-names></name>, <name><surname>Brazionis</surname><given-names>L</given-names></name>, <name><surname>Kaimakamis</surname><given-names>M</given-names></name>, <name><surname>Cameron</surname><given-names>M</given-names></name>, <name><surname>Best</surname><given-names>JD</given-names></name>, <name><surname>O’Dea</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study.</article-title><source>Nutr Metab Cardiovasc Dis.</source><year>2011</year>;<volume>21</volume>:<fpage>740</fpage>–<lpage>747</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.numecd.2010.03.005</pub-id>
<?supplied-pmid 20674309?><pub-id pub-id-type="pmid">20674309</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Renaud</surname><given-names>S</given-names></name>, <name><surname>de Lorgeril</surname><given-names>M</given-names></name>, <name><surname>Delaye</surname><given-names>J</given-names></name>, <name><surname>Guidollet</surname><given-names>J</given-names></name>, <name><surname>Jacquard</surname><given-names>F</given-names></name>, <name><surname>Mamelle</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Cretan Mediterranean diet for prevention of coronary heart disease</article-title>. <source>Am J Clin Nutr</source>. <year>1995</year>;<volume>61</volume>:<fpage>1360S</fpage>–<lpage>1367S</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajcn/61.6.1360S</pub-id>
<?supplied-pmid 7754988?><pub-id pub-id-type="pmid">7754988</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Mayneris-Perxachs</surname><given-names>J</given-names></name>, <name><surname>Sala-Vila</surname><given-names>A</given-names></name>, <name><surname>Chisaguano</surname><given-names>M</given-names></name>, <name><surname>Castellote</surname><given-names>AI</given-names></name>, <name><surname>Estruch</surname><given-names>R</given-names></name>, <name><surname>Covas</surname><given-names>MI</given-names></name>, <etal>et al</etal>. <article-title>Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk.</article-title><source>PLoS ONE.</source><year>2014</year>;<volume>9</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0085202</pub-id>
<?supplied-pmid 24651160?><pub-id pub-id-type="pmid">24651160</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Vincent-Baudry</surname><given-names>S</given-names></name>, <name><surname>Defoort</surname><given-names>C</given-names></name>, <name><surname>Gerber</surname><given-names>M</given-names></name>, <name><surname>Bernard</surname><given-names>MC</given-names></name>, <name><surname>Verger</surname><given-names>P</given-names></name>, <name><surname>Helal</surname><given-names>O</given-names></name>, <etal>et al</etal>. <article-title>The Medi-RIVAGE study: Reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet</article-title>. <source>Am J Clin Nutr</source>. <year>2005</year>;<volume>82</volume>:<fpage>964</fpage>–<lpage>971</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajcn/82.5.964</pub-id>
<?supplied-pmid 16280426?><pub-id pub-id-type="pmid">16280426</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Hagfors</surname><given-names>L</given-names></name>, <name><surname>Nilsson</surname><given-names>I</given-names></name>, <name><surname>Sköldstam</surname><given-names>L</given-names></name>, <name><surname>Johansson</surname><given-names>G</given-names></name>. <article-title>Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis.</article-title><source>Nutr Metab</source>. <year>2005</year>;<volume>2</volume>:<fpage>26</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1743-7075-2-26</pub-id><?supplied-pmid 16216119?><pub-id pub-id-type="pmid">16216119</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>CR</given-names></name>, <name><surname>Bryan</surname><given-names>J</given-names></name>, <name><surname>Hodgson</surname><given-names>JM</given-names></name>, <name><surname>Wilson</surname><given-names>C</given-names></name>, <name><surname>Dhillon</surname><given-names>V</given-names></name>, <name><surname>Murphy</surname><given-names>KJ</given-names></name>. <article-title>A randomised controlled intervention trial evaluating the efficacy of an Australianised Mediterranean diet compared to the habitual Australian diet on cognitive function, psychological wellbeing and cardiovascular health in healthy older adults (MedLey study): Protocol paper.</article-title><source>BMC Nutr</source>. <year>2015</year>;<volume>1</volume>:<fpage>35</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40795-015-0033-7</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>C</given-names></name>, <name><surname>Hodgson</surname><given-names>J</given-names></name>, <name><surname>Bryan</surname><given-names>J</given-names></name>, <name><surname>Garg</surname><given-names>M</given-names></name>, <name><surname>Woodman</surname><given-names>R</given-names></name>, <name><surname>Murphy</surname><given-names>K</given-names></name>. <article-title>Older Australians Can Achieve High Adherence to the Mediterranean Diet during a 6 Month Randomised Intervention; Results from the Medley Study.</article-title><source>Nutrients</source>. <year>2017</year>;<volume>9</volume>:<fpage>534</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/nu9060534</pub-id><?supplied-pmid 28538676?><pub-id pub-id-type="pmid">28538676</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Lampe</surname><given-names>JW</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name><surname>Tinker</surname><given-names>LF</given-names></name>, <name><surname>Song</surname><given-names>X</given-names></name>, <name><surname>Schoeller</surname><given-names>DA</given-names></name>, <etal>et al</etal>. <article-title>Dietary biomarker evaluation in a controlled feeding study in women from the Women’s Health Initiative cohort</article-title>. <source>Am J Clin Nutr</source>. <year>2017</year>;<volume>105</volume>:<fpage>466</fpage>–<lpage>475</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/ajcn.116.144840</pub-id>
<?supplied-pmid 28031191?><pub-id pub-id-type="pmid">28031191</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Pennant</surname><given-names>M</given-names></name>, <name><surname>Steur</surname><given-names>M</given-names></name>, <name><surname>Moore</surname><given-names>C</given-names></name>, <name><surname>Butterworth</surname><given-names>A</given-names></name>, <name><surname>Johnson</surname><given-names>L</given-names></name>. <article-title>Comparative validity of vitamin C and carotenoids as indicators of fruit and vegetable intake: a systematic review and meta-analysis of randomised controlled trials</article-title>. <source>Br J Nutr</source>. <year>2015</year>;<volume>114</volume>:<fpage>1331</fpage>–<lpage>1340</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/S0007114515003165</pub-id>
<?supplied-pmid 26349405?><pub-id pub-id-type="pmid">26349405</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Hodson</surname><given-names>L</given-names></name>, <name><surname>Skeaff</surname><given-names>CM</given-names></name>, <name><surname>Fielding</surname><given-names>BA</given-names></name>. <article-title>Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake</article-title>. <source>Prog Lipid Res</source>. <year>2008</year>;<volume>47</volume>:<fpage>348</fpage>–<lpage>380</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.plipres.2008.03.003</pub-id>
<?supplied-pmid 18435934?><pub-id pub-id-type="pmid">18435934</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>X</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name><surname>Tinker</surname><given-names>LF</given-names></name>, <name><surname>Vitolins</surname><given-names>MZ</given-names></name>, <name><surname>Prentice</surname><given-names>RL</given-names></name>, <etal>et al</etal>. <article-title>Dietary long-chain fatty acids and carbohydrate biomarker evaluation in a controlled feeding study in participants from the Women’s Health Initiative cohort</article-title>. <source>Am J Clin Nutr</source>. <year>2017</year>;<volume>105</volume>:<fpage>1272</fpage>–<lpage>1282</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/ajcn.117.153072</pub-id>
<?supplied-pmid 28446501?><pub-id pub-id-type="pmid">28446501</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Lemaitre</surname><given-names>RN</given-names></name>, <name><surname>King</surname><given-names>IB</given-names></name>. <article-title>Very long-chain saturated fatty acids and diabetes and cardiovascular disease</article-title>. <source>Curr Opin Lipidol</source>. <year>2022</year>;<volume>33</volume>:<fpage>76</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/MOL.0000000000000806</pub-id>
<?supplied-pmid 34907969?><pub-id pub-id-type="pmid">34907969</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Langenberg</surname><given-names>C</given-names></name>, <name><surname>Sharp</surname><given-names>S</given-names></name>, <name><surname>Forouhi</surname><given-names>NG</given-names></name>, <name><surname>Franks</surname><given-names>PW</given-names></name>, <name><surname>Schulze</surname><given-names>MB</given-names></name>, <name><surname>Kerrison</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Design and cohort description of the InterAct Project: An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study</article-title>. <source>Diabetologia</source>. <year>2011</year>;<volume>54</volume>:<fpage>2272</fpage>–<lpage>2282</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00125-011-2182-9</pub-id>
<?supplied-pmid 21717116?><pub-id pub-id-type="pmid">21717116</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Barua</surname><given-names>AB</given-names></name>, <name><surname>Kostic</surname><given-names>D</given-names></name>, <name><surname>Olson</surname><given-names>JA</given-names></name>. <article-title>New simplified procedures for the extraction and simultaneous high-performance liquid chromatographic analysis of retinol, tocopherols and carotenoids in human serum</article-title>. <source>J Chromatogr B Biomed Sci Appl</source>. <year>1993</year>;<volume>617</volume>:<fpage>257</fpage>–<lpage>264</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0378-4347(93)80496-q</pub-id>
<?supplied-pmid 8408391?><pub-id pub-id-type="pmid">8408391</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Tu</surname><given-names>WC</given-names></name>, <name><surname>Mühlhäusler</surname><given-names>BS</given-names></name>, <name><surname>Yelland</surname><given-names>LN</given-names></name>, <name><surname>Gibson</surname><given-names>RA</given-names></name>. <article-title>Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats.</article-title><source>Prostaglandins Leukot Essent Fat Acids.</source><year>2013</year>;<volume>88</volume>:<fpage>53</fpage>–<lpage>60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.plefa.2012.04.005</pub-id>
<?supplied-pmid 22521090?><pub-id pub-id-type="pmid">22521090</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Brevik</surname><given-names>A</given-names></name>, <name><surname>Andersen</surname><given-names>LF</given-names></name>, <name><surname>Karlsen</surname><given-names>A</given-names></name>, <name><surname>Trygg</surname><given-names>KU</given-names></name>, <name><surname>Blomhoff</surname><given-names>R</given-names></name>, <name><surname>Drevon</surname><given-names>CA</given-names></name>. <article-title>Six carotenoids in plasma used to assess recommended intake of fruits and vegetables in a controlled feeding study.</article-title><source>Eur J Clin Nutr</source>. <year>2004</year>;<volume>58</volume>:<fpage>1166</fpage>–<lpage>1173</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601945</pub-id>
<?supplied-pmid 15054430?><pub-id pub-id-type="pmid">15054430</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>JS</given-names></name>, <name><surname>Sharp</surname><given-names>SJ</given-names></name>, <name><surname>Imamura</surname><given-names>F</given-names></name>, <name><surname>Chowdhury</surname><given-names>R</given-names></name>, <name><surname>Gundersen</surname><given-names>TE</given-names></name>, <name><surname>Steur</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries</article-title>. <source>BMJ</source>. <year>2020</year>;<volume>370</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.m2194</pub-id><?supplied-pmid 32641421?><pub-id pub-id-type="pmid">32641421</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Summerhill</surname><given-names>K</given-names></name>, <name><surname>Rodriguez-Canas</surname><given-names>C</given-names></name>, <name><surname>Mather</surname><given-names>I</given-names></name>, <name><surname>Patel</surname><given-names>P</given-names></name>, <name><surname>Eiden</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies</article-title>. <source>Genome Med</source>. <year>2013</year>;<volume>5</volume>:<fpage>39</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/gm443</pub-id><?supplied-pmid 23618465?><pub-id pub-id-type="pmid">23618465</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Forouhi</surname><given-names>NG</given-names></name>, <name><surname>Koulman</surname><given-names>A</given-names></name>, <name><surname>Sharp</surname><given-names>SJ</given-names></name>, <name><surname>Imamura</surname><given-names>F</given-names></name>, <name><surname>Kröger</surname><given-names>J</given-names></name>, <name><surname>Schulze</surname><given-names>MB</given-names></name>, <etal>et al</etal>. <article-title>Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: The EPIC-InterAct case-cohort study</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2014</year>;<volume>2</volume>:<fpage>810</fpage>–<lpage>818</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2213-8587(14)70146-9</pub-id>
<?supplied-pmid 25107467?><pub-id pub-id-type="pmid">25107467</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Wareham</surname><given-names>NJ</given-names></name>, <name><surname>Jakes</surname><given-names>RW</given-names></name>, <name><surname>Rennie</surname><given-names>KL</given-names></name>, <name><surname>Schuit</surname><given-names>J</given-names></name>, <name><surname>Mitchell</surname><given-names>J</given-names></name>, <name><surname>Hennings</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.</article-title><source>Public Health Nutr.</source><year>2003</year>;<volume>6</volume>:<fpage>407</fpage>–<lpage>413</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1079/PHN2002439</pub-id>
<?supplied-pmid 12795830?><pub-id pub-id-type="pmid">12795830</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Riboli</surname><given-names>E</given-names></name>, <name><surname>Hunt</surname><given-names>K</given-names></name>, <name><surname>Slimani</surname><given-names>N</given-names></name>, <name><surname>Ferrari</surname><given-names>P</given-names></name>, <name><surname>Norat</surname><given-names>T</given-names></name>, <name><surname>Fahey</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.</article-title><source>Public Health Nutr.</source><year>2002</year>;<volume>5</volume>:<fpage>1113</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1079/PHN2002394</pub-id><?supplied-pmid 12639222?><pub-id pub-id-type="pmid">12639222</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Slimani</surname><given-names>N</given-names></name>, <name><surname>Deharveng</surname><given-names>G</given-names></name>, <name><surname>Unwin</surname><given-names>I</given-names></name>, <name><surname>Southgate</surname><given-names>DAT</given-names></name>, <name><surname>Vignat</surname><given-names>J</given-names></name>, <name><surname>Skeie</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>The EPIC nutrient database project (ENDB): A first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study.</article-title><source>Eur J Clin Nutr</source>. <year>2007</year>;<volume>61</volume>:<fpage>1037</fpage>–<lpage>1056</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602679</pub-id>
<?supplied-pmid 17375121?><pub-id pub-id-type="pmid">17375121</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Su</surname><given-names>M</given-names></name>, <name><surname>Jia</surname><given-names>E</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data.</article-title><source>Sci Rep.</source><year>2018</year>;<volume>8</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-017-19120-0</pub-id><?supplied-pmid 29330539?><pub-id pub-id-type="pmid">29330539</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Stryker</surname><given-names>WS</given-names></name>, <name><surname>Kaplan</surname><given-names>LA</given-names></name>, <name><surname>Stein</surname><given-names>EA</given-names></name>, <name><surname>Stampfer</surname><given-names>MJ</given-names></name>, <name><surname>Sober</surname><given-names>A</given-names></name>, <name><surname>Willett</surname><given-names>WC</given-names></name>. <article-title>The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels</article-title>. <source>Am J Epidemiol</source>. <year>1988</year>;<volume>127</volume>:<fpage>283</fpage>–<lpage>296</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a114804</pub-id>
<?supplied-pmid 3257350?><pub-id pub-id-type="pmid">3257350</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>H</given-names></name>, <name><surname>Hastie</surname><given-names>T</given-names></name>. <article-title>Regularization and variable selection via the elastic net.</article-title><source>J R Stat Soc Ser B</source>. <year>2005</year>;<volume>67</volume>:<fpage>301</fpage>–<lpage>320</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1467-9868.2005.00503.x</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Ounpraseuth</surname><given-names>S</given-names></name>, <name><surname>Lensing</surname><given-names>SY</given-names></name>, <name><surname>Spencer</surname><given-names>HJ</given-names></name>, <name><surname>Kodell</surname><given-names>RL</given-names></name>. <article-title>Estimating misclassification error: A closer look at cross-validation based methods.</article-title><source>BMC Res Notes.</source><year>2012</year>;<volume>5</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1756-0500-5-656</pub-id><?supplied-pmid 23190936?><pub-id pub-id-type="pmid">23190936</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Hoerl</surname><given-names>AE</given-names></name>, <name><surname>Kennard</surname><given-names>RW</given-names></name>. <article-title>Ridge Regression: Applications to Nonorthogonal Problems.</article-title><source>Technometrics</source>. <year>1970</year>;<volume>12</volume>:<fpage>69</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/00401706.1970.10488635</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Hanley</surname><given-names>JA</given-names></name>, <name><surname>McNeil</surname><given-names>BJ</given-names></name>. <article-title>The meaning and use of the area under a receiver operating characteristic (ROC) curve.</article-title><source>Radiology</source>. <year>1982</year>;<volume>143</volume>:<fpage>29</fpage>–<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1148/radiology.143.1.7063747</pub-id>
<?supplied-pmid 7063747?><pub-id pub-id-type="pmid">7063747</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Prentice</surname><given-names>RL</given-names></name>. <article-title>A case-cohort design for epidemiologic cohort studies and disease prevention trials</article-title>. <source>Biometrika</source>. <year>1986</year>;<volume>73</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/biomet/73.1.1</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Riley</surname><given-names>RD</given-names></name>, <name><surname>Higgins</surname><given-names>JPT</given-names></name>, <name><surname>Deeks</surname><given-names>JJ</given-names></name>. <article-title>Interpretation of random effects meta-analyses</article-title>. <source>BMJ</source>. <year>2011</year>;<volume>342</volume>:<fpage>964</fpage>–<lpage>967</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.d549</pub-id>
<?supplied-pmid 21310794?><pub-id pub-id-type="pmid">21310794</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>White</surname><given-names>IR</given-names></name>. <article-title>Multivariate random-effects meta-analysis.</article-title><source>Stata J</source>. <year>2009</year>;<volume>9</volume>:<fpage>40</fpage>–<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1536867x0900900103</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>White</surname><given-names>IR</given-names></name>, <name><surname>Royston</surname><given-names>P</given-names></name>, <name><surname>Wood</surname><given-names>AM</given-names></name>. <article-title>Multiple imputation using chained equations: Issues and guidance for practice.</article-title><source>Stat Med.</source><year>2011</year>;<volume>30</volume>:<fpage>377</fpage>–<lpage>399</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.4067</pub-id>
<?supplied-pmid 21225900?><pub-id pub-id-type="pmid">21225900</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Seaman</surname><given-names>SR</given-names></name>, <name><surname>Bartlett</surname><given-names>JW</given-names></name>, <name><surname>White</surname><given-names>IR</given-names></name>. <article-title>Multiple imputation of missing covariates with non-linear effects and interactions: An evaluation of statistical methods.</article-title><source>BMC Med Res Methodol.</source><year>2012</year>;<volume>12</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2288-12-46</pub-id><?supplied-pmid 22489953?><pub-id pub-id-type="pmid">22489953</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Newson</surname><given-names>RB</given-names></name>. <article-title>Attributable and unattributable risks and fractions and other scenario comparisons.</article-title><source>Stata J.</source><year>2013</year>;<volume>13</volume>:<fpage>672</fpage>–<lpage>698</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1536867x1301300402</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Kalbfleisch</surname><given-names>JD</given-names></name>, <name><surname>Lawless</surname><given-names>JF</given-names></name>. <article-title>Likelihood analysis of multi-state models for disease incidence and mortality.</article-title><source>Stat Med</source>. <year>1988</year>;<volume>7</volume>:<fpage>149</fpage>–<lpage>160</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.4780070116</pub-id>
<?supplied-pmid 3353602?><pub-id pub-id-type="pmid">3353602</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref053">
                <label>53</label>
                <mixed-citation publication-type="book"><name><surname>Connolly</surname><given-names>SE</given-names></name>. <source>Beyond Parameter Estimation: Analysis of the Case-Cohort Design in Cox Models (Doctoral thesis).</source><publisher-name>University of Cambridge</publisher-name>; <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.17863/CAM.51383</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Van Calster</surname><given-names>B</given-names></name>, <name><surname>McLernon</surname><given-names>DJ</given-names></name>, <name><surname>Van Smeden</surname><given-names>M</given-names></name>, <name><surname>Wynants</surname><given-names>L</given-names></name>, <name><surname>Steyerberg</surname><given-names>EW</given-names></name>, <name><surname>Bossuyt</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Calibration: The Achilles heel of predictive analytics.</article-title><source>BMC Med.</source><year>2019</year>;<volume>17</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12916-019-1466-7</pub-id><?supplied-pmid 31842878?><pub-id pub-id-type="pmid">31842878</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Nattino</surname><given-names>G</given-names></name>, <name><surname>Lemeshow</surname><given-names>S</given-names></name>, <name><surname>Phillips</surname><given-names>G</given-names></name>, <name><surname>Finazzi</surname><given-names>S</given-names></name>, <name><surname>Bertolini</surname><given-names>G</given-names></name>. <article-title>Assessing the calibration of dichotomous outcome models with the calibration belt.</article-title><source>Stata J.</source><year>2017</year>;<volume>17</volume>:<fpage>1003</fpage>–<lpage>1014</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1536867X1801700414</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>CR</given-names></name>, <name><surname>Bryan</surname><given-names>J</given-names></name>, <name><surname>Hodgson</surname><given-names>JM</given-names></name>, <name><surname>Wilson</surname><given-names>C</given-names></name>, <name><surname>Murphy</surname><given-names>KJ</given-names></name>. <article-title>Older Australians can adhere to a traditional Mediterranean style diet over two weeks: A pilot dietary intervention study.</article-title><source>BMC Nutr.</source><year>2015</year>;<volume>1</volume>:<fpage>1</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40795-015-0021-y</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>IntHout</surname><given-names>J</given-names></name>, <name><surname>Ioannidis</surname><given-names>JPA</given-names></name>, <name><surname>Rovers</surname><given-names>MM</given-names></name>, <name><surname>Goeman</surname><given-names>JJ</given-names></name>. <article-title>Plea for routinely presenting prediction intervals in meta-analysis</article-title>. <source>BMJ Open</source>. <year>2016</year>;<volume>6</volume>:<fpage>e010247</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2015-010247</pub-id><?supplied-pmid 27406637?><pub-id pub-id-type="pmid">27406637</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Guasch-Ferré</surname><given-names>M</given-names></name>, <name><surname>Bhupathiraju</surname><given-names>SN</given-names></name>, <name><surname>Hu</surname><given-names>FB</given-names></name>. <article-title>Use of Metabolomics in Improving Assessment of Dietary Intake</article-title>. <source>Clin Chem</source>. <year>2018</year>;<volume>64</volume>:<fpage>82</fpage>–<lpage>98</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1373/clinchem.2017.272344</pub-id>
<?supplied-pmid 29038146?><pub-id pub-id-type="pmid">29038146</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Hidalgo-Liberona</surname><given-names>N</given-names></name>, <name><surname>Meroño</surname><given-names>T</given-names></name>, <name><surname>Zamora-Ros</surname><given-names>R</given-names></name>, <name><surname>Rabassa</surname><given-names>M</given-names></name>, <name><surname>Semba</surname><given-names>R</given-names></name>, <name><surname>Tanaka</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Adherence to the Mediterranean diet assessed by a novel dietary biomarker score and mortality in older adults: the InCHIANTI cohort study.</article-title><source>BMC Med.</source><year>2021</year>;<fpage>19</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12916-021-02154-7</pub-id><?supplied-pmid 34814922?><pub-id pub-id-type="pmid">33430856</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref060">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Marklund</surname><given-names>M</given-names></name>, <name><surname>Magnusdottir</surname><given-names>OK</given-names></name>, <name><surname>Rosqvist</surname><given-names>F</given-names></name>, <name><surname>Cloetens</surname><given-names>L</given-names></name>, <name><surname>Landberg</surname><given-names>R</given-names></name>, <name><surname>Kolehmainen</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A Dietary Biomarker Approach Captures Compliance and Cardiometabolic Effects of a Healthy Nordic Diet in Individuals with Metabolic Syndrome</article-title>. <source>J Nutr</source>. <year>2014</year>;<volume>144</volume>:<fpage>1642</fpage>–<lpage>1649</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3945/jn.114.193771</pub-id>
<?supplied-pmid 25080537?><pub-id pub-id-type="pmid">25080537</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Gerber</surname><given-names>M.</given-names></name><article-title>Qualitative methods to evaluate Mediterranean diet in adults.</article-title><source>Public Health Nutr</source>. <year>2006</year>;<volume>9</volume>:<fpage>147</fpage>–<lpage>151</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1079/phn2005937</pub-id>
<?supplied-pmid 16512962?><pub-id pub-id-type="pmid">16512962</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref062">
                <label>62</label>
                <mixed-citation publication-type="journal"><name><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name><surname>Patterson</surname><given-names>RE</given-names></name>, <name><surname>King</surname><given-names>IB</given-names></name>, <name><surname>Horner</surname><given-names>NK</given-names></name>, <name><surname>Lampe</surname><given-names>JW</given-names></name>. <article-title>Selected nutritional biomarkers predict diet quality.</article-title><source>Public Health Nutr</source>. <year>2003</year>;<volume>6</volume>:<fpage>703</fpage>–<lpage>709</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1079/phn2003486</pub-id>
<?supplied-pmid 14552672?><pub-id pub-id-type="pmid">14552672</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Medina-Remón</surname><given-names>A</given-names></name>, <name><surname>Tresserra-Rimbau</surname><given-names>A</given-names></name>, <name><surname>Pons</surname><given-names>A</given-names></name>, <name><surname>Tur</surname><given-names>JA</given-names></name>, <name><surname>Martorell</surname><given-names>M</given-names></name>, <name><surname>Ros</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2015</year>;<volume>25</volume>:<fpage>60</fpage>–<lpage>67</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.numecd.2014.09.001</pub-id>
<?supplied-pmid 25315667?><pub-id pub-id-type="pmid">25315667</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref064">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Guasch-Ferré</surname><given-names>M</given-names></name>, <name><surname>Chung</surname><given-names>W</given-names></name>, <name><surname>Ruiz-Canela</surname><given-names>M</given-names></name>, <name><surname>Toledo</surname><given-names>E</given-names></name>, <name><surname>Corella</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>The Mediterranean diet, plasma metabolome, and cardiovascular disease risk</article-title>. <source>Eur Heart J</source>. <year>2020</year>;<fpage>1</fpage>–<lpage>14</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/eurheartj/ehaa209</pub-id>
<?supplied-pmid 32406924?><pub-id pub-id-type="pmid">32876668</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref065">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Salas-Salvadó</surname><given-names>J</given-names></name>, <name><surname>Bulló</surname><given-names>M</given-names></name>, <name><surname>Estruch</surname><given-names>R</given-names></name>, <name><surname>Ros</surname><given-names>E</given-names></name>, <name><surname>Covas</surname><given-names>MI</given-names></name>, <name><surname>Ibarrola-Jurado</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial</article-title>. <source>Ann Intern Med</source>. <year>2014</year>;<volume>160</volume>:<fpage>1</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7326/M13-1725</pub-id>
<?supplied-pmid 24573661?><pub-id pub-id-type="pmid">24573661</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref066">
                <label>66</label>
                <mixed-citation publication-type="journal"><name><surname>Roncero-Ramos</surname><given-names>I</given-names></name>, <name><surname>Alcala-Diaz</surname><given-names>JF</given-names></name>, <name><surname>Rangel-Zuñiga</surname><given-names>OA</given-names></name>, <name><surname>Gomez-Delgado</surname><given-names>F</given-names></name>, <name><surname>Jimenez-Lucena</surname><given-names>R</given-names></name>, <name><surname>García-Rios</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study</article-title>. <source>Clin Nutr</source>. <year>2020</year>;<volume>39</volume>:<fpage>492</fpage>–<lpage>500</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.clnu.2019.02.027</pub-id>
<?supplied-pmid 30852029?><pub-id pub-id-type="pmid">30852029</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref067">
                <label>67</label>
                <mixed-citation publication-type="journal"><name><surname>de Koning</surname><given-names>L</given-names></name>, <name><surname>Chiuve</surname><given-names>SE</given-names></name>, <name><surname>Fung</surname><given-names>TT</given-names></name>, <name><surname>Willett</surname><given-names>WC</given-names></name>, <name><surname>Rimm</surname><given-names>EB</given-names></name>, <name><surname>Hu</surname><given-names>FB</given-names></name>. <article-title>Diet-quality scores and the risk of type 2 diabetes in men</article-title>. <source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>:<fpage>1150</fpage>–<lpage>1156</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/dc10-2352</pub-id>
<?supplied-pmid 21464460?><pub-id pub-id-type="pmid">21464460</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref068">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Potischman</surname><given-names>N</given-names></name>. <article-title>Biologic and methodologic issues for nutritional biomarkers.</article-title><source>J Nutr</source>. <year>2003</year>;<volume>133</volume>:<fpage>875S</fpage>–<lpage>880S</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jn/133.3.875S</pub-id>
<?supplied-pmid 12612173?><pub-id pub-id-type="pmid">12612173</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref069">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Prentice</surname><given-names>RL</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>. <article-title>Nutritional epidemiology methods and related statistical challenges and opportunities.</article-title><source>Stat Theory Relat Fields</source>. <year>2018</year>;<volume>2</volume>:<fpage>2</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/24754269.2018.1466098</pub-id>
<?supplied-pmid 30778402?><pub-id pub-id-type="pmid">30778402</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref070">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Jenab</surname><given-names>M</given-names></name>, <name><surname>Slimani</surname><given-names>N</given-names></name>, <name><surname>Bictash</surname><given-names>M</given-names></name>, <name><surname>Ferrari</surname><given-names>P</given-names></name>, <name><surname>Bingham</surname><given-names>SA</given-names></name>. <article-title>Biomarkers in nutritional epidemiology: Applications, needs and new horizons</article-title>. <source>Hum Genet</source>. <year>2009</year>;<volume>125</volume>:<fpage>507</fpage>–<lpage>525</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00439-009-0662-5</pub-id>
<?supplied-pmid 19357868?><pub-id pub-id-type="pmid">19357868</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Ferreri</surname><given-names>C</given-names></name>, <name><surname>Masi</surname><given-names>A</given-names></name>, <name><surname>Sansone</surname><given-names>A</given-names></name>, <name><surname>Giacometti</surname><given-names>G</given-names></name>, <name><surname>Larocca</surname><given-names>A</given-names></name>, <name><surname>Menounou</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Fatty Acids in Membranes as Homeostatic, Metabolic and Nutritional Biomarkers: Recent Advancements in Analytics and Diagnostics.</article-title><source>Diagnostics.</source><year>2016</year>;<volume>7</volume>:<fpage>1</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/diagnostics7010001</pub-id><?supplied-pmid 28025506?><pub-id pub-id-type="pmid">28025506</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Bell</surname><given-names>ML</given-names></name>, <name><surname>Kenward</surname><given-names>MG</given-names></name>, <name><surname>Fairclough</surname><given-names>DL</given-names></name>, <name><surname>Horton</surname><given-names>NJ</given-names></name>. <article-title>Differential dropout and bias in randomised controlled trials: when it matters and when it may not</article-title>. <source>BMJ</source>. <year>2013</year>;<fpage>346</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.e8668</pub-id><?supplied-pmid 23338004?><pub-id pub-id-type="pmid">23338004</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Verbeek</surname><given-names>JH</given-names></name>, <name><surname>Whaley</surname><given-names>P</given-names></name>, <name><surname>Morgan</surname><given-names>RL</given-names></name>, <name><surname>Taylor</surname><given-names>KW</given-names></name>, <name><surname>Rooney</surname><given-names>AA</given-names></name>, <name><surname>Schwingshackl</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>An approach to quantifying the potential importance of residual confounding in systematic reviews of observational studies: A GRADE concept paper.</article-title><source>Environ Int.</source><year>2021</year>;<volume>157</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.envint.2021.106868</pub-id><?supplied-pmid 34530289?><pub-id pub-id-type="pmid">34530289</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref074">
                <label>74</label>
                <mixed-citation publication-type="journal"><name><surname>Bellou</surname><given-names>V</given-names></name>, <name><surname>Belbasis</surname><given-names>L</given-names></name>, <name><surname>Tzoulaki</surname><given-names>I</given-names></name>, <name><surname>Evangelou</surname><given-names>E</given-names></name>. <article-title>Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses</article-title>. <source>PLoS ONE</source>. <year>2018</year>;<volume>13</volume>:<fpage>1</fpage>–<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0194127</pub-id>
<?supplied-pmid 29558518?><pub-id pub-id-type="pmid">29558518</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref075">
                <label>75</label>
                <mixed-citation publication-type="journal"><name><surname>Greenland</surname><given-names>S</given-names></name>, <name><surname>Schlesselman</surname><given-names>JJ</given-names></name>, <name><surname>Criqui</surname><given-names>MH</given-names></name>. <article-title>The fallacy of employing standardized regression coefficients and correlations as measures of effect</article-title>. <source>Am J Epidemiol</source>. <year>1986</year>;<volume>123</volume>:<fpage>203</fpage>–<lpage>208</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a114229</pub-id>
<?supplied-pmid 3946370?><pub-id pub-id-type="pmid">3946370</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>L</given-names></name>, <name><surname>Brunius</surname><given-names>C</given-names></name>, <name><surname>Johansson</surname><given-names>I</given-names></name>, <name><surname>Bergdahl</surname><given-names>IA</given-names></name>, <name><surname>Lindahl</surname><given-names>B</given-names></name>, <name><surname>Hanhineva</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Plasma metabolites associated with healthy Nordic dietary indexes and risk of type 2 diabetes—a nested case-control study in a Swedish population</article-title>. <source>Am J Clin Nutr</source>. <year>2018</year>;<volume>108</volume>:<fpage>564</fpage>–<lpage>575</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajcn/nqy145</pub-id>
<?supplied-pmid 30060042?><pub-id pub-id-type="pmid">30060042</pub-id></mixed-citation>
              </ref>
              <ref id="pmed.1004221.ref077">
                <label>77</label>
                <mixed-citation publication-type="journal"><name><surname>Trepanowski</surname><given-names>JF</given-names></name>, <name><surname>Ioannidis</surname><given-names>JPA</given-names></name>. <article-title>Perspective: Limiting dependence on nonrandomized studies and improving randomized trials in human nutrition research: Why and how.</article-title><source>Adv Nutr</source>. <year>2018</year>;<volume>9</volume>:<fpage>367</fpage>–<lpage>377</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/advances/nmy014</pub-id>
<?supplied-pmid 30032218?><pub-id pub-id-type="pmid">30032218</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
